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ABSTRACT 
 
Protein aggregation occurs under many circumstances, from the dynamic 
assembly of tubulin to form microtubules, the aggregation of actin into filaments, as well 
as plaque formation by amyloid precipitation.  One important requirement in studying the 
mechanism of amyloid aggregation is the ability to monitor the growth kinetics over a 
wide range in size scales (10 nm to microns) with time that spans microseconds to 
seconds.  Understanding the mechanisms of the aggregation may then lead to improved 
design of drugs to help control or suppress the aggregation process.  
In this dissertation, the physical characterization of the β-amyloid peptide and its 
interaction with αα-amino acid peptide-based mediators was investigated from the early, 
rapidly evolving stage to the later, slowly diffusing peptide stage by the application of 
fluorescence photobleaching recovery (FPR).  The diffusion rates of β-amyloid peptide 
and β-amyloid assemblies under the effects of variables including concentration of β-
amyloid, blocker peptide, ionic strength, pH, time and temperature were accessible by 
this method.  In some instances, dynamic light scattering (DLS), which acquire signals 
greater than 10 decades of lag times, without requiring a dye label was used for 
comparison and to account for the limitations of any given approach.  Attachment of 5-
carboxyfluorescein did not affect the integrity of the protein and the measured diffusion 
coefficients were similar to those measured by diffusion ordered spectroscopy (DOSY) 
and from theoretical expectations.  FPR proved more sensitive than DLS for detection of 
low oligomer aggregates of the β-amyloid peptide coexisting with much larger fibrils. We 
were able to reverse the conformation of the peptide from the low oligomeric state to the 
 xvii  
aggregated state under neutral and acidic pH conditions and confirmed that the peptide 
growth increased with increasing ionic strength.  
The interaction of β-amyloid peptide with membranes results in several 
membrane-perturbing effects which may play a pivotal role in the pathogenic cascade 
leading to Alzheimer’s disease. Model phospholipid bilayer membranes consisting of 1-
Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphocholine (POPC) and 1-Oleoyl-2-[12-[(7-nitro-
2-1,3-benzoxadiazol-4-yl)amino] dodecanoyl]-sn-Glycero-3-Phosphocholine (18:1-12:0 
NBD PC) were prepared on mica. FPR proved to be a useful technique for obtaining 
























 1  
CHAPTER 1 
INTRODUCTION 
1.1 Proteins and Peptides 
 
Proteins are macromolecules that are essential to the structure and function of all 
living organisms. The primary structure of a protein consists of a linear chain of amino 
acids linked by amide bonds. There are twenty standard amino acids, and it is possible to 
create many unique sequences of very long chains of amino acids, resulting in proteins 
with high molecular masses. Shorter chains with typically less than fifty amino acids are 
called peptides. The function of proteins and peptides are dependent on their shape.  
 In order for proteins to perform their biological function, they must fold into the 
correct higher order three-dimensional structures. The folding and unfolding kinetics of 
proteins ranges from being fast (microseconds) and simple, with one single exponential 
function of time1 to being slow (years). Regardless of the wide range of time frames, 
proteins fold into complex shapes whereby minimum energy is used to maintain stability 
in its native conformation. The ability of proteins to spontaneously fold into their lowest 
energy native conformation depends on the interaction of their amino acid sequence with 
environmental conditions like (solvent, pH, ionic strength, presence of other components 
such as metal ions or prosthetic groups, temperature, and other).2 Pioneering studies by 
Christian Anfinsen demonstrated that an unfolded protein (ribonuclease) could 
spontaneously refold (by removal of certain chemicals or lowering the temperature) into 
its native conformation in a test tube, thus concluding that proper protein folding is 
primarily dependent upon the interactions of the amino acid sequence in a given 
environment.   
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 While normal physiological conditions predisposes the manner in which a 
protein’s amino acid sequence folds into its native structure, there exists conditions 
(extremes of pH, temperature) under which a protein will misfold or become unfolded. 
Disruption in the normal protein folding pathway can result in potentially detrimental 
consequences in the cellular environment. Incorrectly folded proteins that are essential to 
normal cellular function may encounter difficulty in performing their biological function, 
thus leading to malfunctioning of living systems and ultimately disease.3  
Several human diseases are associated with the improper folding of proteins that 
result in cellular malfunction.4   These include Alzheimer’s disease, Parkinson’, cystic 
fibrosis, cancer and Tay-Sachs.  While the exact mechanisms by which loss of function 
occurs vary, researchers were able to categorize some diseases into three main groups – 
defective proteins due to mutagenesis, amyloidosis and mislocalization.  Mutations often 
alter a protein sequence causing changes in the overall protein structure, which may result 
in partial or complete loss of protein function. In contrast, amyloidosis results from the 
accumulation of misfolded protein aggregations outside the cell forming insoluble 
amyloid fibrils which have been associated with having a toxic function. A list of 
diseases grouped according to mutant proteins and the associated molecular defect 
appears in Table 1.1.5   
Alzheimer’s disease (AD) is a neurodegenerative disorder and the leading cause of 
dementia affecting majority of the elderly population.  While neuropathologically, the 
brains of individuals with the disease are characterized by insoluble extracellular amyloid 
plaques and fibrils6, clinically, the disease progresses with gradual memory loss, changes 
in behavior and disorientation. As the population ages, it is estimated that the number of 
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Table 1.1  Some putative protein folding diseases (adapted from Ref. 5) 
Disease 
 
Mutant protein/protein  
 involved 
Molecular phenotype 
Inability to fold 
  
Cystic fibrosis CFTR Misfolding/altered Hsp70 
and calnexin interactions 
Marfan syndrome Fibrillin Misfolding 
Amyotrophic lateral 
sclerosis 
Superoxide dismutase Misfolding 
Scurvy Collagen Misfolding 
Maple syrup urine disease α-Ketoacid dehydrogenase 
complex 
Misassembly/misfolding 
Cancer P53 Misfolding/altered Hsp70 
interaction 




    Familial insomnia 
Prion protein Aggregation 
Alzheimer’s disease β-Amyloid Aggregation 
Familial amyloidosis Transthyretin/lysozyme Aggregation 
Cataracts Crystallins Aggregation 
Mislocalization owing to misfolding 
Familial 
hypercholesterolemia 
LDL receptor Improper trafficking 
α1-Antitrypsin Deficiency α1-Antitrypsin Improper trafficking 
Tay-Sachs disease β-Hexosaminidase Improper trafficking 
Retinitis pigmentosa Rhodopsin Improper trafficking 
Leprechaunism Insulin receptor Improper trafficking 
 
people with the disease will continue to increase.7  Thus, development of therapeutic 
targets for inhibition of the disease is of utmost importance. Despite rapid advances in the 
research findings in the past decade, at the moment, there is no cure for the disease.  
Nevertheless, researchers are continually striving to design new strategies for curbing the 
progression of the disease.   
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1.2 Aims of This Study 
The main emphasis in this dissertation research is the use of fluorescence 
photobleaching recovery (FPR) and dynamic light scattering (DLS) in the detection of the 
early intermediates in protofibril formation and subsequently β-amyloid peptide self-
assembly. This study will use β-amyloid1-40 (Aβ) and fluorescently (5-carboxy-
fluorescein) labeled β-amyloid1-40 mixtures at a variety of concentrations and 
physiological conditions to determine the diffusion rates of β-amyloid peptide and β-
amyloid assemblies.  The effects of variables including concentration β-amyloid, ionic 
strength, pH, time and temperature are accessible by these methods. Following reliable 
studies of the β-amyloid monomer association and aggregation, the physical properties of 
‘inhibitor’ molecules, including, de novo peptide-based molecules designed by Robert P. 
Hammer and their effectiveness at mediating amyloidoses was assessed. 
Dynamic light scattering (DLS) was initially used to assess the earliest stages of 
β-amyloid self-assembly. Monomeric Aβ, which is a 4KD peptide, scarcely scatters 
above solvent level at the concentrations of interest. Thus, DLS in the early stage of Aβ 
self-assembly proved challenging, but with a choice of powerful frequency doubled diode 
and Argon ion lasers, a variety of detectors, and high-coherence single-mode fiber optic 
detection as an option, signals could be obtained. Even so, and despite discriminating 
custom software to analyze multiple runs in an efficient graphical fashion, distinguishing 
the expected aggregates from dust remained a major issue. Moreover, aggregates were 
sometimes present at low numbers in the detected volume, which leads to unwanted 
number fluctuations. Taken together, these problems made it difficult to establish “clean 
start” conditions to assess ‘inhibitor’ efficiency. It was decided that the best use of DLS 
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was to screen inhibitor molecules for efficiency by testing their effect on larger 
assemblies. To further establish “clean starting” conditions to study the effect of inhibitor 
molecules on Aβ assembly, the dissociation of the peptide was monitored under high 
pressure. 
Fluorescence photobleaching recovery technique was a suitable alternative to 
remediate the deficiencies of DLS from the standpoint of aggregation mechanism, despite 
the requirement of having a fluorophore attached to the molecule of interest. FPR would 
improve the economy of experimenting with the expensive Aβ peptide and inhibitor 
molecules, in addition to addressing questions such as the reversibility of the Aβ peptide. 
An in situ dialysis cell was designed and used to determine diffusion coefficients by FPR. 
The diffusion coefficients were easily converted to size through Stoke’s law because the 
system is very dilute. FPR was also used to assess the fluidity of lipid membranes upon 
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CHAPTER 2 
BACKGROUND AND LITERATURE REVIEW 
2.1 Cleavage of β-Amyloid Peptide from APP  
It has been suggested that the accumulation of amyloid-β (Aβ) is the primary 
influence driving AD pathogenesis.8;9 In 1984, Glenner and Wong10;11 reported the first 
sequence of Aβ isolated from the principal protein component in AD brain. The Aβ 
peptide was found to vary in length from 39-43 amino acid residues due to proteolytic 
cleavage of the transmembrane glycoprotein, amyloid-β precursor protein (APP) by α, β, 
and γ-secretases, as shown in Figure 2.1. The α-secretase cleaves APP within the Aβ 
sequence producing soluble nonamyloidogenic fragments, which is a normal constituent 
of human biological fluids,12 whereas cleavage by the β-secretase (extracellular, produces 
the NH2 terminus), and γ-secretase (intracellular, produces the COOH terminus) releases 
the toxic Aβ fragment from APP. The Aβ1-40 and Aβ1-42 are the predominant forms 
and the peptide. The normal physiological function of APP remains uncertain, but it has 
been shown that some possible functions may include cell proliferation13, cell adhesion14, 
neurite outgrowth15, and neuronal migration.16 
2.2 Properties of β-Amyloid Peptide 
  The term amyloid was originally used by German physician and scientist, Rudolf 
Virchow, to describe proteinaceous aggregates associated with diseases as shown in 
Table 1.1 because some of their properties resembled those of (amylase, cellulose) 
starch.4;17 Virchow was able to recognize amyloid by tinctorial properties elicited when 
amyloid-laden tissues were treated with iodine at the autopsy table.18 Later, amyloid 
deposits were characterized by diagnostic staining methods, x-ray diffraction and electron 
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microscopy to investigate the molecular structure of the fibrils. The early investigations 
indicated that all amyloids, regardless of the disease involved or the source of the fibrils, 












Figure 2.1 Schematic of β-amyloid (1-40) peptide location within the amyloid precursor 
protein and it representative amino acid sequence. 
 
 
(i) the molecular structure of all amyloids is such that the fibrils bind Congo 
Red and interact with the dye in such a way that it appears red 
microscopically in normal light and has a characteristic apple green 
birefringence20;21 under polarized light; 
(ii) in the electron microscope amyloid deposits can be seen to be composed 
of uniform, straight unbranched fibers, approx. 10 nm in diameter and of 
indefinite length – longer than 200 nm 22; the fibers are usually straight or 
slightly curved which suggests they have a particularly rigid molecular 
structure; 
N 
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(iii) amyloid x-ray diffraction patterns show that the ordered, repeating 
molecular structure of the fibrils consists of polypeptide chains in an 
extended β-conformation, hydrogen-bonded together into sheets which run 
parallel to the axis of the fibril and which have their constituent β-strands 
arranged perpendicular to this axis, the so-called ‘cross-β’ 
conformation23;24.  An x-ray diffraction pattern25 from paired helical 
filaments (PHF) purified from Alzheimers’ patients cerebral cortex is 
shown in Figure 2.2. 
(iv) amyloid protein aggregates were also found to be insoluble in common 
solvents and detergents, and protease resistance.26  
 
Figure 2.2 (a) X-ray diffraction pattern from a partially oriented, dried PHF pellet from 
Alzheimer cerebral cortex.25  The beam was directed normal to the fiber axis, which is 
vertical.  The meridionally accentuated arcs at 0.476- nm spacing are indicated by the 
arrowheads, and the equatorially accentuated arcs centered at about 1.06- nm spacing are 
indicated by the arrows.   (b) Schematic diagram summarizing the analysis of the x-ray 
diffraction pattern from (a) indicating β conformation.23;24  
 
(a) (b) 
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These early studies have now been extended by more detailed examinations of ex 
vivo amyloid27 and synthetic amyloid28-30 with a range of techniques (mentioned below), 
and it is now evident that while amyloids composed of different proteins belong to the 
same class of substance, with similar or identical core structures, there are some 
significant differences between them. 
2.3 Literature Review 
Many researchers are involved in understanding the role of β-amyloid peptide in 
the pathogenesis of Alzheimer’s disease and designing strategies to prevent or slow the 
disease progression. A wide variety of instrumental techniques, such as analytical 
ultracentrifugation (AUC), dynamic light scattering (DLS), static light scattering (SLS), 
diffusion-ordered spectroscopy (DOSY), circular dichroism spectroscopy (CD), electron 
microscopy (EM), atomic force microscopy (AFM) and scanning force microscopy 
(SFM), have been used to study the formation and aggregation properties of β-amyloid 
peptide. The results from all these methods gave interesting insights into the mechanism 
of amyloid formation and growth, but with the availability of new techniques, additional 
progress will be made to enrich our understanding of the protein aggregation process.  
This brief review of previous studies will highlight the strengths and limitations of 
individual instrumental techniques used in the characterization of β-amyloid peptide and 
cases when it was necessary to use a combination of techniques for comparison and to 
augment the deficiencies of a given method. 
          Plaques that develop in the brains of Alzheimer’s patients are built up from fibrils 
composed of hundreds or more β-amyloid peptide (Aβ) molecules.31 Thus, a central 
question in the etiology of AD is the mechanism(s) by which these Aβ molecules are 
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converted into plaque-associated fibers.32;33 Two instrumental techniques that have been 
used to provide information about fiber formation34-37 and inhibition38;39 are dynamic and 
static light scattering. Analysis of scattered light from particles in a solution illuminated 
by a coherent light source provides a means for monitoring macromolecular association 
in solution in real time.40 The data are heavily weighted toward larger particles; thus, the 
method is most sensitive to the species of most interest-aggregated Aβ. 
        Pallitto et al. combined static and dynamic light scattering as a means to characterize 
the interactions of several hybrid peptides with Aβ in solution. One advantage to using 
light scattering was the fact that no probe molecules or labels that could potentially 
interfere with Aβ aggregation was needed. Furthermore, quantitative information on 
changes in the average size and morphology of particles is readily extracted from the 
data. The DLS results of this study found that the best inhibitors as measured by 
protection from toxicity, appeared to alter Aβ aggregation by increasing the rate of 
aggregation. The inconsistency of this result was removed when SLS measurements 
showed that the altering aggregate morphology was due to branching of the fibrils. That 
is, the growth proceeded by consecutive association of Aβ onto the ends of existing 
fibrils.41-43 
      Another instrumental technique that has been useful for providing information about 
aggregate morphology is electron microscopy. Several studies have utilized EM to obtain 
structural information about the fibril formation process.24;44-49 In a “seeded” 
polymerization mechanism, a small amount of preformed amyloid fibrils is added to a 
solution of Aβ peptide.20;50 It is believed that prior to fibril formation, oligomeric 
intermediates must form. Early kinetic studies of Aβ fibrillization failed to detect any 
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intermediate species.51 Thus, while EM is useful for visualizing changes in fibril 
formation, it is difficult to quantify and provides limited information about the 
aggregation process. Other methods that have failed to distinguish between fibrillar 
morphologies of Aβ are turbidimetry and sedimentation. Although small oligomeric Aβ 
species have been separated by analytical ultracentrifugation, (it was observed that at 450 
µM, Aβ1-40 produces a slowly sedimenting species, which in addition to the rapidly 
sedimenting, probably fibrillar material52 detailed structural information is still lacking.  
        This shortcoming was corrected by the use of AFM analysis, a technique providing 
three-dimensional information about species adsorbed to surfaces without the need for 
extensive sample preparation.45;53 Because AFM provides a three-dimensional 
characterization of the fibril, it offers distinct advantage over traditional electron 
microscopy.54 In a study by Harper et al., AFM was used to follow amyloid fibril 
formation in vitro by the Aβ variants Aβ1-40 and Aβ1-42. Small elongated Aβ 
oligomers, which was termed ‘protofibrils’, (possible intermediates in the assembly of 
amyloid fibrils) was observed.55 It is difficult to decide whether the protofibrils are 
assembly precurcors of the fibrils or whether the protofibrils are in fast equilibrium with 
monomeric Aβ. This demonstrates a limitation of AFM to provide quantifiable kinetic 
effects. An alternate technique would be fluorescence photobleaching recovery (FPR), 
although the structural detail would be lacking. 
        Although FPR has never been used to study amyloid systems, a comparative 
method, fluorescence correlation spectroscopy (FCS), has been used to overcome the lack 
of selectively in light scattering.56;57 FCS detects spontaneous fluctuations in the 
fluorescence emission of small molecular ensembles.56;58-60 Theoretical advantages of 
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FCS are balanced by practical experimental advantages of FPR.61 Another self-diffusion 
technique, pulsed field gradient NMR, has been used to study the extent of Aβ 
aggregation; however, the methodology was deemed of limited utility for very large 
aggregates due to unfavorable nuclear relaxation properties.62;63 Thus, FPR should be a 
valuable complement to both FCS and pulsed field gradient NMR.  
 One important requirement in studying the mechanism of protein aggregation is 
the ability to monitor continuously the kinetics of fibril growth and to identify the 
intermediate stages of this process. Experimental data relating to the early stages of 
amyloid aggregation are difficult to obtain.64 In an attempt to elucidate information about 
the kinetics and different sizes spanning the range expected during peptide aggregation, 
the experimental technique must be able to measure both rapidly and slowly diffusing 
peptide aggregates. Fluorescence photobleaching recovery (FPR) is a well-established 
technique for the measurement of diffusion coefficients. This study will investigate the 
formation of β-amyloid aggregation at various stages by FPR, thus marking the first 
application of the highly selective FPR method to amyloid research. It should prove a 
valuable complement to additional characterization techniques that has been used to 
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CHAPTER 3 
 




High pressure has been known to cause conformational changes in proteins for 
over a hundred years. In 1899, B. H. Hite reported the use of high pressure for milk (β-
lactoglobulin) preservation.65 Fifteen years later, P.W. Bridgman discovered that raw egg 
(albumen, lysozyme) appeared cooked after high hydrostatic pressure treatment.66  
 Although few papers exist in the literature since the earliest studies, in the past 
decade there has been a resurgence in the use of high pressure technology ranging from 
understanding the fundamentals of protein disaggregation and refolding67-70, to 
application in the food industry.71-73 High pressure is becoming an increasingly popular 
biophysical technique for studying protein folding and structural dynamics; this is 
important to gain insight into diseases associated with protein misfolding. The immense 
interest in the food industry is due to adaptation of existing high pressure technologies for 
utilization in both food preservation and preparation (processing and packaging of 
materials).  High pressure treatment may potentially preserve several properties of food 
ingredients (color, flavor, nutritional value, texture, taste)72 with minimal effect on final 
product quality. For example, high pressure treatment of milk inactivates the enzymatic 
activity of microbes to prevent spoilage, in addition to enhancing the coagulation 
properties of milk.71 In order to further exploit the use of high pressure technologies for 
applications in biotechnology (protein therapeutics, design of novel vaccines and antiviral 
drugs74), and the food industry (dairy, meats, and vegetables), it is paramount to 
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understand the impact of high pressure on the structure and conformational changes of 
proteins. 
 Several researchers have investigated the effect of high pressure on protein 
structure and self-assembly properties. High pressure has been used successfully to 
dissociate both oligomeric and complex-aggregated proteins. Paladini et al. reported that 
hydrostatic pressure in the range of 1 bar – 3 kbar was able to dissociate proteins 
(enolase, yeast hexokinase) from the oligomeric form into subunits.75;76  Much more 
complicated protein systems (brome mosaic virus77 and mitochondrial ATP synthase78) 
have also been dissociated with high pressure.79 High pressure treatment was shown to 
reduce the aggregation rates of denatured proteins during refolding.67;80 St. John et al. 
used high pressures (1-2 kbar) combined with low, nondenaturing concentrations of 
guanidine hydrochloride (GdnHCl) as an alternative to strong chaotrophic salts to 
disaggregate and refold proteins.70 Thus high pressure can eliminate the need for dilution 
of reagents, buffer changes, or modification of reaction conditions.70;80 
 The mode of action of high pressure on protein dissociation has been 
experimentally confirmed to depend on the penetration of water into the protein 
matrix.68;81-86 Proteins have been found to contain small “free volumes” within their 
folded conformation due to restrictions in amino acids proximity to each other. This 
results in internal cavities and packing defects that make them sensitive to pressure.68 
Application of high pressure disrupts the hydrophobic and electrostatic interactions 
within the protein structure which results in a decrease in the volume of the system.67;72;84 
Consequently, packing of solvent molecules is more efficient following protein 
dissociation. 
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Several amyloidogenic proteins aggregate into stable, predominantly β-sheet 
fibrillic structures which are insoluble in common solvents.50;51 These protein aggregates 
are implicated in several diseases. In Alzheimer’s disease, the β-amyloid (Aβ) peptide is 
the major component of these aggregates. There is an urgent need for efficient methods to 
hinder aggregate formation as this may lead to design of potential therapeutics.   
Although significant progress has been made in understanding the mechanisms of 
protein aggregate formation, several challenges remain. Among these, obtaining 
reproducible starting materials (monomeric Aβ peptide) for biophysical characterization 
has been of utmost priority. The existing chemical protocols to disaggregate the Aβ 
peptide are time-consuming, and/or expensive; worse, the likelihood that some pre-
seeded Aβ may still exist in the starting material cannot be ignored. As high pressure 
treatment has proven to be a successful tool in dissociating proteins, it may help 
circumvent some of these problems. 
The objective of this study is to investigate the application of high pressure to 
dissociate Aβ peptide into monomeric subunits. High pressure is a powerful, physical 
method that has been shown to dissociate the amyloidogenic protein transthyretin, with 
the possibility of achieving stable intermediates when pressure and temperature are 
carefully “tuned”.68 The aggregation state of the Aβ peptide prior to experiment is critical 
for obtaining reproducible results. This is particularly important when screening and 
characterizing new peptides.  Use of an inadequate array of biophysical techniques would 
be costly overall. Thus, we used a high pressure system in order to obtain ‘stable’ Aβ starting 
material for testing the efficiency of blocker peptides upon interaction with the Aβ peptide.   
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3.2 Materials and Methods 
• Reagents and Chemicals 
 All reagents were of analytical grade. Hydrostatic liquid was spectroscopic-grade 
ethanol with a low-fluorescence background signal. Distilled water was filtered and 
deionized through a Millipore water purification system (18 MΩ resistance). β-
amyloid(1-40) (Catalog No. 24236) was purchased from Anaspec, Inc. (San Jose, CA).  
Phosphoric acid (99.999%, Catalog No. 34,524-5) and semiconductor-grade potassium 
hydroxide (99.99%, Catalog No. 30,656-8) were obtained from Aldrich Chemical Co. 
Sodium chloride (99.999%, Catalog No. 10862) was obtained from Alfa Aesar.  (2-[N-
Morpholino] ethane-sulfonic acid, MES) was purchased from Sigma (Catalog No. M-
8250).  
• Sample Preparation 
The high pressure experiments were performed at two locations, identified as 
Location A (UNICAMP, Sao Paulo, Brazil) and Location B (Louisiana State University, 
LA). Both locations were equipped with similar high pressure system with the difference 
being the information obtained. In Location A, the information obtained was the change 
in light scattering intensity of the sample with response to increasing high pressure 
(recorded with an Edingburg FL 900 spectrofluorometer). In Location B, the information 
obtained was the change in size (radius) of the sample with response to increasing and 
decreasing high pressure (recorded with a dynamic light scattering (DLS) instrument). 
The β-amyloid1-40 (Aβ) samples (500 µM stock solution) were solubilized according to 
the method of Aucoin.87  Briefly, stock solutions were prepared by dissolving the peptide 
in filtered 10 mM KOH (pH 11) and vortexing with a Daigger Vortex Genie 2 until 
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completely dissolved.  The Aβ peptide is known to exist in a monomeric state under 
sufficiently basic conditions.45 Otherwise, the stock was adjusted to the appropriate 
concentration and pH values. In location A, the buffers used were 100 mM MES buffer at 
pH 5.5 and 50 mM Tris chloride buffer, 150 mM NaCl, at pH 7.4. In Location B, several 
buffers were used but the presence of large aggregates in solution exceeded the 
capabilities of DLS. Results were obtained in the  50 mM phosphate buffered saline, 150 
mM NaCl, pH 7.4 and 50 mM Tris chloride buffer, 150 mM NaCl, at pH 7.4. 
• Light scattering and fluorescence under pressure (Location A, UNICAMP, Sao 
Paulo, Brazil) 
 
 The high-pressure system has been described elsewhere.88 An ISS model 
(HPCell™, Champaign, IL USA) high-pressure cell with sapphire windows connected to 
a pressure generator (HIP) was used. The intensity of light scattered at 340 nm was 
recorded in an Edinburg FL 900 spectrofluorometer and was measured at an angle of 90° 
relative to the incident light using the same wavelength for the excitation and emission 
monochromators. The fluorescence data were obtained at an excitation wavelength of 280 
nm and an emission of 290-400 nm. 
 The pressure system was automated and controlled by software denominated 
“Automa” written in Delphi 5.0 language and compatible with Windows. A computer 
controlled a series of devices, including: (1) a servomotor connected to an induction 
motor that was coupled to the pressure generator, (2) the fluorometer monochromators 
for excitation and emission, and (3) the step motors for the excitation and emission slits. 
The software received information from a pressure gauge via an analog interface 
connected to a 14-bit analog-digital board that allowed the control of pressure in real 
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time, while data from the detectors were obtained via an RS232 serial port. All data were 
processed in ASCII format and displayed on x-y plots. 
• Dynamic light scattering under pressure (Location B, Louisiana State University, 
LA) 
 
 A similar setup as described previously was used for DLS with the exception that 
the pump was manually operated. The light scattering instrument is described in Chapter 
4. Details and photograph (courtesy of Rafael Cueto) of the set-up is provided in 
Appendix B. 
3.3 Results 
• Light scattering intensity results (Location A) 
 To examine the effect of pressure on Aβ aggregates, an initial sample of peptide 
was prepared in MES buffer under conditions known to produce immediate aggregates. 
Figure 3.1, (top) shows the effect of pressure on a 50 µM Aβ solution in 100 mM MES 
buffer at pH 5.5. Light scattering showed a decrease of intensity with increasing pressure, 
implying that the Aβ aggregates were being dissociated. Upon the return to atmospheric 
pressure, the samples were inverted to check for precipitation of the sample at the bottom 
on the sample cell, but no aggregates were observed visually.  After about two hours at 
atmospheric pressure, the same sample (Aβ run #1) was subjected to high pressure a 
second time (Aβ run #2). The light scattering results followed an identical trend to the 
first sample. The only intrinsic fluorophore present in the Aβ peptide sequence is the 
aromatic side-chain of the tyrosine (Tyr 10) molecule. Although tyrosine has a low 
quantum yield, its sensitivity was measurable by fluorescence spectroscopy.78 Thus, the 
effect of pressure on the fluorescence of the sample was probed to ascertain whether 
changes due to the tyrosine residues occurred. Figure 3.1, (middle) shows the 
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fluorescence intensity response of the Aβ peptide to increasing pressure. After an initial 
decrease in the fluorescence intensity, at pressures above 10,000 psi the fluorescence 
intensity stabilized.  
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Figure 3.1 Effect of pressure on the light scattering intensity and fluorescence properties 
of β-amyloid peptide (Aβ). Top: light scattering intensity of an Aβ solution with a 
concentration of 50 µM in 100 mM MES buffer, pH 5.5 subjected to high pressure. 
Middle: Fluorescence properties of β-amyloid peptide solution in the top figure.  
                                                                                                                   (figure continued) 
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Figure 3.1 (continued) Bottom: Fluorescence emission spectra of Aβ solution in the 
middle figure and corresponding plot of maximum fluorescence as a function of pressure. 
The excitation wavelength was 280 nm. Each spectrum data was collected 5 minutes after 
the pressure value had stabilized. 
 
The increasing pressure had negligible effect on the tyrosine groups in the sample. This 
suggests that perhaps there are no major structural changes in the microenvironment of 
the fluorophore. The emission spectra characteristic of tyrosine groups as a function of 
increasing pressure is illustrated in Figure 3.1, (bottom).  
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To further test whether the Aβ peptide aggregates were being dissociated by high 
pressure, the supernatant of the starting 50 µM Aβ solution in 100 mM MES buffer, pH 
5.5 (collected after centrifuging the sample at 14,000 x g for 30 minutes) was subjected to 
high pressure. Figure 3.2 (top) shows that the light scattering intensity is decreasing as a 
function of pressure and leveled off at about 30,000 psi. The light scattering change is not 
as dramatic as in Figure 3.1 (top), suggesting that further dissociation of the sample may 
be due to the presence of minor amounts of aggregates in the solution. The light 
scattering data of the Aβ supernatant solution is plotted with the aggregated sample for 
comparison (Figure 3.2, bottom). 




































Figure 3.2 Changes in light scattering of Aβ peptide as a function of pressure. Top: light 
scattering intensity of an Aβ ‘supernatant’ solution with a concentration of 50 µM in 100 
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Figure 3.2 (continued) Bottom: Superposition of light scattering data for both the 
aggregated and supernatant Aβ solution. Each spectrum was collected 5 minutes after the 
pressure value had stabilized. 
 
After observing that it was possible to dissociate aggregated Aβ solution prepared 
in MES buffer, a more ‘common’ buffer system was used. A fresh 50 µM Aβ solution in 
50 mM Tris-Cl buffer at pH 7.4 was subjected to high pressure. Figure 3.3, top and 
bottom shows the light scattering and the corresponding fluorescence intensity results 
obtained. Both plots show similar trend in the light scattering and fluorescence intensity. 
At low pressure up to 7,000 psi a sharp increase in the scattering and fluorescence 
intensity was observed, followed by the opposite effect, namely a decrease in intensity at 
higher pressures up to a value of about 17,000 psi. The experiment was terminated at this 
pressure value due to technical problems (malfunctioning pressure gauge) with the 
instrument. 
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Although the instrumental problems mentioned above was solved, it turned out to 
be ‘temporarily fixed’ as the problem recurred during acquisition of the data in Figure 
3.4. The effect of high pressure on the light scattering intensity of Aβ in the presence of 
Amy1 peptide was investigated. First, the light scattering of a 50 µM Aβ peptide prepared 
in 50 mM Tris-Cl buffer, pH 7.4, under high pressure was monitored. The increase and 
subsequent decrease in the light scattering intensity at low and high pressure respectively, 
suggest that at low pressure the peptide’s structure is changing (increasing size) perhaps 
due to interaction with the solvent molecules, while at higher pressure values the opposite 
effect (decreasing size) may be due to dissociation of the peptide. 





























Figure 3.3 Effect of pressure on the scattering and fluorescence intensity of β-Amyloid 
peptide. Top: Light scattering intensity of 50 µM Aβ in 50 mM Tris-Cl buffer, pH 7.4. 
                                                                                                                   (figure continued) 
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Figure 3.3 (continued) Bottom: Fluorescence intensity of 50 µM Aβ in 50 mM Tris-Cl 
buffer, pH 7.4. 
 
 
The high pressure effect on the light scattering of the 50 µM Amy1 peptide prepared in 
water was then monitored. The inset in Figure 3.4 shows an enhanced scale of the trend 
in the scattering intensity of the Amy1 peptide under high pressure. The light scattering 
signal remained uniform at both low and high pressure, implying that the Amy1 peptide 
was stable under high pressure treatment.  The sample containing a 1:1 molar ratio of Aβ 
and Amy1 petide was then subjected to high pressure treatment. The general trend in the 
data suggests that the combinded Aβ and Amy1 peptides were being dissociated, as the 
light scattering intensity signal steadily decreased with increasing pressure. Additional 
experiments could not be performed due to continued problems with the instrument’s 
pressure gauge. 
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Figure 3.4 Effect of high pressure on the light scattering of β-amyloid peptide and Amy1 
peptide-based mediator. Inset shows adjustment of y-axis to show trend in the effect of 
high pressure on the light scattering of 50 µM Amy1 peptide dissolved in water. 
 
 
• Dynamic light scattering results (Location B) 
 
Although it would have been advantageous to measure the light scattering 
intensity and corresponding size of the Aβ peptide, the instrument in Location A lacked 
that capability. An opportunity to measure the effect of high pressure on the size of Aβ 
peptide at a different location (Location B) was presented. The initial experiment to 
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investigate the dissociation of Aβ aggregates prepared in MES buffer, as done at Location 
A proved very challenging for dynamic light scattering as the aggregates were too large. 
The alternate buffer choice used was 50 mM Tris-Cl, pH 7.4. Figure 3.5 shows the effect 
of increasing and decreasing pressure on the hydrodynamic radius of Aβ peptide in Tris-
Cl buffer. The initial hydrodynamic radius calculated was about 116 ± 4.0 nm. This value 
very slightly increased to 148 ± 18 nm at the highest pressure of 35,000 psi. Upon 
decreasing the pressure, differences between the initial and final radius of the sample was 
negligible, suggesting stabilization of the sample. There was no substantial effect (within 
experimental error) of high pressure on the size of the Aβ peptide in Tris-Cl buffer. 
As most of the initial investigations of Aβ peptide were performed in phosphate 
buffer, this buffer system was chosen (neglecting the effect of pressure on the buffer 
itself) to study the effect of high pressure on Aβ peptide in this solvent environment. A 
50 µM Aβ sample was subjected to high pressure in 50 mM PBS buffer, pH 7.4. Figure 
3.6 shows the changes in hydrodynamic radius of Aβ as a function of increasing and 
decreasing pressure. There is a steady increase in the radius of the peptide with increasing 
pressure. At the highest pressure, the radius increased to 480 ± 4.3 nm, a difference of 
about 100 nm from the initial radius (376 ± 1.8 nm) at atmospheric pressure. The radius 
decreased to a value of 434 ± 3.2 nm at 10,000 psi and appeared to level off at 5,000 psi, 
suggesting stabilization of the sample. One of the most likely explanations to the 
increasing radius is that in the phosphate buffer environment, any dissociation of the Aβ 
peptide induced by pressure is exposing the hydrophobic sites on the peptide to the 
solvent, promoting interactions which leads to the observed increased in hydrodynamic 
radius.   
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Figure 3.5 Effect of high pressure on the hydrodynamic radius of Aβ. A 50 µM Aβ 
sample subjected to high pressure in 50 mM PBS buffer, pH 7.4. Error bars are standard 
deviation of triplicate runs. 
 
 
The sample was kept at atmospheric pressure for one day and subsequently subjected to 
high pressure. Figure 3.6, middle, shows the effect of high pressure on the radius of the 
Aβ peptide after one day at atmospheric pressure following the first pressure cycle. The 
peptide radii were identical with negligible error (standard deviation of triplicate runs) 
during both the increase and decrease of pressure. A final radius of 325 nm was obtained 
which is slightly smaller than the initial radius of 376 nm at the start of the experiment. 
The results obtained for both pressure cycles of the effect of pressure on the radius of Aβ 
are plotted for comparison (Figure 3.6, bottom). 
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         Cycle #2
After 1 day at atmospheric 










Figure 3.6 Dynamic light scattering results of increasing and decreasing pressure on β-
amyloid Aggregation. Top: Hydrodynamic radius plotted against increasing and 
decreasing pressure. Middle: Hydrodynamic radius plotted against increasing and  
decreasing pressure.                                                                                  (figure continued) 
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 Increase Pressure (1st cycle)
 Decrease Pressure (1st cycle)
 Increase Pressure (2nd cycle)
 Decrease Pressure (2nd cycle)
 




 The main goal of this study was to use hydrostatic pressure to dissociate Aβ 
peptide to obtain reproducible starting Aβ solution. The results obtained with light 
scattering and fluorescence intensity measurements demonstrated that high pressure is an 
efficient technique to dissociate Aβ aggregates and obtain stable material. For the effect 
of high pressure on the size of Aβ peptide in both 50 mM Tris-Cl and 50 mM PBS, 150 
mM NaCl, pH 7.4, the results did not show the expected trend corresponding to Aβ 
dissociation. Rather, in the 50 mM Tris-Cl solvent environment, there was negligible 
change in the size of the Aβ peptide for both increasing and decreasing pressure. In the 
PBS environment, there was an initial increase in radius with increasing pressure and the 
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opposite effect upon decreasing the pressure, with stabilization of the radius at low 
pressures. Subjecting the Aβ peptide in the PBS environment to a second cycle of 
increasing and decreasing pressures demonstrated that the sample had stabilized with no 
changes in the peptide radius during both increasing and decreasing pressure.  
The data in Figures 3.5 and 3.6 were measured at an angle of 90° at various 
pressures, using a conventional dynamic light scattering instrument (modified for 
accommodating the high pressure cell). As only a single angle was used, the 
hydrodynamic radii represent apparent values. In both figures, the presence of large 
aggregates at low and high pressure, were easily detected by DLS. Small aggregates were 
not detected, but their presence could not be confirmed or denied; indicating one 
limitation of DLS for preferentially detecting larger species. Nonetheless, the results 
obtained using single angle measurements were adequate for observing any effect of high 
pressure on the aggregation properties of Aβ. Overall, these results suggest that it is 
possible to obtain stable samples (within the experimental time frame) of Aβ peptide 
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CHAPTER 4 
 




 Protein transport plays a critical role in how the mammalian central nervous 
system communicates with the rest of the body. Important to the function of this 
sophisticated transport system is the blood-brain barrier (BBB). If the structural 
complexity of the system is ignored, the BBB can simply be described as a “gatekeeper” 
of the central nervous system which regulates the passage of substances.89 Protein and 
peptide ligand gain entry into or out of the brain and spinal cord by either simple 
diffusion or saturable transport.89 An example of this concept is the transport of the β-
amyloid peptide (Aβ) out of the brain. It is believed that the normal function of the 
transport system is to facilitate the removal of Aβ from the brain.90-92 Failure of the 
transport system to clear the Aβ results in formation of amyloid plaque. Alzheimer’s 
disease is a detrimental consequence of amyloid plaque accumulation in the brain. A 
major goal is to understand the mechanisms of Aβ transport and plaque formation in an 
effort to design therapeutic approaches to solve this problem. 
While it is often a challenge to exactly emulate nature, scientists continue to find 
ways to explore and answer many fundamental questions. For instance, fluorescence 
photobleaching recovery (FPR) was originally developed to examine the dynamics of 
living cells in vitro. The first application of FPR was geared towards understanding the 
effect of membrane transport on the physiological states of cells.93-97  Recent reviews of 
this technique describe the proliferation of this method as well as a host of applications.98-
105 Like FPR, dynamic light scattering (DLS) is also a powerful tool for studying 
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molecular diffusion. The theory of DLS relevant to this study is described below. 
Complete theoretical background of DLS can be found elsewhere.106-108 
4.2 Theoretical Background 
Mutual diffusion is a transport process in which there is a net flow of molecules, 
normally from a region of high concentration to one of low concentration.  Self diffusion 
is also “natural” and does not involve the high-to-low change. Fick proposed that the 
flow of matter along a concentration gradient should be analogous to the law of heat flow 
along a temperature gradient.109   The product of diffusion coefficient and concentration 
gradient is a measure of the flux and can be seen in the equation below, known as Fick’s 
first law of diffusion: 
                                                    J = - Dm (
dx
dc )   (1) 
 
where J represents the flux with units of square centimeter per second, c has  
concentration units, and Dm is the mutual diffusion coefficient with units of centimeter 
squared per second.  The subscript represents mutual diffusion coefficient and it is the 
diffusion coefficient obtained from measuring relaxation of the concentration gradient.  
Diffusion depends on molecular size according to the Stokes-Einstein equation: 
 
       f
kTD =
    (2)   
   
 
where k is the Boltzmann constant, T is the Kelvin temperature and f is the size-, shape-, 
and concentration-dependent friction coefficient.  For a spherical particle with a 
hydrodynamic radius Rh when dispersed at low concentrations in a solvent of viscosity 
ηo, the friction coefficient is given by f = 6πηoRh.  Translational diffusion can be used to 
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determine the size and shape of individual molecules as well as molecular aggregates.  
Dynamic light scattering is a useful technique for the measurement of motion of 
molecules by the fluctuations in intensity. One measures the autocorrelation function of 
the scattered light, g(1) (t), which contains information from its distribution of the 
relaxation rate that can be used to determine molecular size.  The decay follows a single 
exponential profile:                                                 
           g (1) (t) = e -Γ t   (3) 
 
where Γ  is the decay rate, proportional to the diffusion coefficient by: 
 
                                                       Γ = q2 Dm    (4) 
 
in which q is the scattering vector magnitude, q = (4πn/λo) sin(θ /2), n is the refractive 
index of the solution, λo is the in vacuo incident light wavelength and the scattering angle 
is θ.  A plot of Γ vs. q2 should be linear with a zero intercept and slope D.  The apparent 
mutual diffusion coefficient, Dapp = Γ /q2 is computed to test whether this is the case.  A 
plot of Dapp vs. q2 should be flat.  Failure of Γ vs. q2 to rise linearly, or a slanted Dapp vs. 
q2 plot, indicates particle heterogeneity and/or a shape other than spherical.  This 
behavior can then be used to evaluate the apparent hydrodynamic radius, Rh,app of 
molecules via the Stokes-Einstein equation:  






  (5) 
 
where k is the Boltzmann’s constant, and η is the solvent viscosity at temperature T. 
 In addition to the mutual diffusion, there exists a self-diffusion that also depends 
on concentration, but self-diffusion happens even without a concentration gradient.  Self-
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diffusion is a measure of the translational motion of a molecule.  The appropriate 
relationship is due to Einstein and it appears in the equations below: 
                    
                                                     <x2> = 2Dst   (6) 
 




2 ><        (7) 
 
The self-diffusion coefficient is referred to as optical tracer self-diffusion coefficient 
when optical methods such as fluorescence photobleaching recovery experiments are 
used to obtain it.  The experimental setup for FPR is explained below.  A distinguishing 
factor observed between mutual and self-diffusion is that for mutual diffusion, 
spontaneous or artificially created fluctuations help drive the diffusion from a region of 
high concentration to one of low concentration, while for self-diffusion, the concentration 
remains almost uniform.  This behavior is observed because in FPR, the concentration of 
the sample is proportional to the concentration of dye before bleaching a stripe pattern 
into the sample. After bleaching, the concentration of the sample does not change, while 
that of the dye changes due to diffusion. If the period of the pattern in the sample is L, 
and the spatial frequency of the pattern is K, then: 
               K = 2π/L               (8) 
In a FPR system equipped with modulation detector, a Ronchi ruling is translated 
perpendicular to its stripes (bleached in the sample). Immediately after bleaching, the 
maximum current at the detector represents a triangle wave, but the high harmonics fade 
so quickly that the sharply defined pattern softens and approaches a sinusoidal wave 
form. The contrast, C(t), of the stripe pattern, which is proportional to a voltage output 
from the modulation detector system, decays exponentially: 
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         C(t) = C0e-Γt  + B                                        (9) 
The baseline, B, represents noise attributed to electronic jitter, imperfections in the cell, 
or artifacts in the sample. The decay rate, Γ = DK2 where D is the tracer self diffusion 
coefficient, K is the grating constant, and t is the time since photobleach.  The diffusion 
coefficient is obtained as the slope of Γ versus K2 plots of the data. Like DLS, the Stokes-
Einstein relation, Ds = kT/(6πηRh) is used to obtain size information and is only valid at c 
= 0, K = 0. Normally, it is safe to assume K = 0 in FPR, while taking the q = 0 limit in 
DLS is much less secure.   
4.3 Characterization Background of FPR 
 
 Fluorescence photobleaching recovery is a powerful diffusion tool used to 
determine the physical properties of fluorescently tagged macromolecules. The theory of 
FPR appears in detail in other sources.110-113 A brief summary of FPR is described. 
The FPR apparatus is set up such that either a spot or fringed pattern is bleached 
on the sample.  In this work, only the modulated fringed pattern was used. The fringe 
pattern is obtained from a Ronchi ruling (a coarse grating in which black stripes are 
etched onto glass at uniform intervals) placed at the back focal plane of the microscope 
objective lens.  A short, intense bleach pulse (writing beam) with duration of less then 
one-tenth of the recovery time irreversibly destroys about 5 to 10% of the fluorescently 
labeled sample. After bleaching, a striped image resulting from the fringed pattern is 
written in the sample. A weak continuous ‘reading’ beam subsequently excites the 
unbleached fluorophores from the ground state to the first excited state. The recovery of 
fluorescence due to redistribution of unbleached molecules into the bleached region of 
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the sample is measured. The rate of recovery provides information about the diffusion of 
the fluorescent molecules. 
4.4 Instrumental Setup of FPR 
The FPR apparatus is shown in Figure 4.1.  The central component of the FPR is 
an Olympus BH2 epifluorescence microscope whose illuminator assembly is modified to 
allow illumination by a light source.  The laser, either a Coherent Innova 90 argon ion 
laser capable of producing 0.9 Watts at 488 nm or a Lexel EXCEL 3000 argon ion laser 
capable of producing 0.9 Watts at 488 nm was used.  The laser beam is passed through an 
acousto-optic modulator (AOM, Newport Research N35085-3) driven by a modified 
radio-frequency source (Newport Research 31085-6DS) which splits the beam into two 
diffraction beams. The first-order diffracted beam, which is about 85% of the laser 
output, is used for photobleaching.  In this study, a fringed pattern is obtained by placing 
a 1” Ronchi ruling (50, 100, 150, and 300 lines/inch, Edmund Scientific), cradled 
between two loudspeakers (4” woofers – Radio Shack catalog number 40-1022B) that 
face each other at the rear image plane of the microscope objective. The speakers are 
driven in push-pull fashion by a low-frequency (typically 16 Hz) triangle wave whose 
amplitude is adjusted to produce an oscillation one half the period of the ruling (or 
multiples thereof).  The input is shorted to stop the speakers during the photobleaching 
step.   
 The patterned beam is deflected by a dichroic mirror and focused by the 
microscope objective (4X, 7X, 10X, and 18X) onto the sample, which sits on a 
temperature-controlled stage.  An RCA 7265 photomultiplier tube (PMT) receives the 
fluorescence from the sample.   The PMT is protected by a shutter (Newport 846HP) that 
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remains close during the photobleaching pulse.  The intensity readout from the 
photodetector is fed to a Stanford Research Systems model SR560 low noise preamplifier 
to filter out unwanted frequencies. The signal is then transmitted to both a Tektronic 
221A 100-MHz digital oscilloscope (to monitor the quality of the sinusoidal wave 
generated in the experiment) and an analog-digital card from National Instruments (# AT-
MI0-16D, Part #320489-01). The output signal of the A/D card is read by a Labview 
generated program which analyzes the sine wave amplitude. The Labview program also 
controls the switching of the AOM, the shutter, and the duration of signal collection. The 
exponentially decaying contrast signal is then analyzed by all the usual analysis 
methods—cumulants,114 single or multiple exponentials with floating baseline, and even 
Laplace inversion115.    
 
Figure 4.1 Schematic of fluorescence photobleaching recovery experimental 
setup(variant of the Lanni and Ware instrument) used in this lab.  AOM=acousto-
optic modulator; M = folding mirrors (an accommodation to space); 
D=diaphragm (stray light reduction); RR=Ronchi Ruling; L= Lens (depends on 
one’s microscope); DM=dichroic mirror; OBJ=Objective (4X – 40X; low N.A.);  
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S=Shutter; PMT=Photomultipler Tube; PA = Preamplifier; TA/PVD = tuned 
amplifier/peak voltage detector.  * indicates point of contact with computer 
multifunction interface card.   
 
4.5 FPR Experimental Protocol 
 One requirement of samples for FPR study is the attachment, preferably covalent, 
of a fluorophore to the molecule of interest. It is important to choose a fluorophore that is 
not easily photobleachable; on the other hand, the fluorophore should not be so stable that 
it is barely bleachable.  In the case of proteins, it is critical to establish that attachment of 
a fluorophore does not affect the functioning of the protein. Once the sample has been 
prepared, a very minute amount is required for doing FPR. The sample is typically loaded 
in 0.1- or 0.2-mm-path-length rectangular microslides (Vitrocom) by capillarity, and the 
microslide is flame-sealed.    A fluorescently labeled dextran is prepared to ensure that 
the instrument is in working condition, particularly after focusing and alignment.  
A sample data trace appears in Figure 4.2, along with the DC signal (equivalent to 
a spot photobleach, but the depth is only about 5%).  The quality of the decaying contrast 
signal approaches that of a typical DLS correlogram after conversion to a first-order 
correlation function. The inset of Figure 4.2 shows a plot of decay rate Γ vs. K2; the lack 
of an intercept confirms the absence of nondiffusive (spontaneous or chemical) recovery 
of the photobleached dye.  
4.6 Characterization Background of DLS 
 
 When laser light is used to illuminate macromolecules, the electrons in the 
molecules are induced to oscillate, due to the oscillating electric field of the light. As the 
molecules will in turn radiate that light, the intensity of the scattered light will depend on 
the magnitude of the dipole induced in the molecules. 
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Figure 4.2 Modulation detector trace for aqueous FITC-Dextran (Sigma FD150).  Top:  
clean contrast recovery (AC) signal after only 5% photobleach of the original intensity, 
DC. Middle: after baseline subtraction, semilogarithmic representation of a single-
exponential behavior.                                                                                (figure continued) 
 40  

















Figure 4.2 (continued) Bottom:  decay rate scales linearly with squared spatial 
frequency.   
 
 
Thus, the larger the dipole induced, means the greater the intensity of the scattered light. 
In solution, the random motion of the molecules will impart randomness to the light 
scattered by these molecules. The relative position of two molecules will determine 
whether the scattered light arriving at a particular position will interfere constructively 
(higher intensity) or destructively (lower intensity). The combined intensity of light 
scattered from several scattering molecules will vary in time, fluctuating around some 
average intensity as the molecules move relative to each other. The rate of the 
fluctuations is related to the rate the molecules are moving through the solvent. On a 
short time scale, these fluctuations will be similar and correlated, thus; analyzing these 
fluctuations can provide information about the molecule size. 
 
 41  
4.7 Instrumental Setup of DLS 
A schematic of the DLS experimental set-up appears in Figure 4.3.  The lasers 
used were either a HeNe laser with wavelength of 632.8 nm or a Coherent Innova 90, 
with wavelength of 488 nm. The device consists of a sample holder with an index 
matching bath containing toluene. The sample is normally placed in 13 mm culture tube 
or borosilicate glass cells (6 x 13 mm, Kimble) which is nearly isorefractive with the bath 
solvent. The electronics consisted of a pulse amplifier/discriminator (PAD, Pacific 
Precision model 126), a Hamamatsu R928p photomultiplier, and an ALV-5000 digital 
multi-tau autocorrelator card installed in a personal computer. Measurements were made 
at multiple scattering angles ranging from 30° to 110° by manually moving a detector 












Figure 4.3 Schematic of dynamic light scattering experimental setup. 
LASER 
θ
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4.8 DLS Experimental Protocol 
Light scattering is very sensitive to large particles and does not distinguish them from 
less interesting particles, such as dust or undissolved material.116 Measures are taken to 
verify that the sample cell (13 mm culture tube) is clean by rinsing repeatedly with dust-
free deionized water from a Barnstead Nanopure water purification system. The cleaned 
tubes are then filled with the same ultrafiltered water and checked for any dust particulate 
by viewing at 30 degrees in the light scattering system. Before the actual samples are 
measured, an unimportant sample is measured to verify that the instrument is correctly 
aligned, and in proper working condition. 
In this case, a latex sample with an advertised diameter of 0.087 µm was used as a 
reference. Figure 4.4 shows the dynamic light scattering results for the latex sample.  
The calculated diameter of the latex particle was 0.089 µm which is in close agreement 
with the advertised diameter. This shows that the instrument is almost perfectly aligned. 














Figure 4.4 Light scattering data for Latex particles. Top: Γ versus q2 plot.  
                                                                                                                   (figure continued) 
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Figure 4.4 (continued) Bottom: Apparent diffusion coefficient plotted as a function of the 




 44  
CHAPTER 5 
 
USE OF FLUORESCENCE PHOTOBLEACHING RECOVERY AND DYNAMIC 




The β-amyloid (Aβ) peptide is believed to play a causative role in the 
pathogenesis of Alzheimer’s disease (AD).8;9;117;118 The exact mechanism through which 
the Aβ induces its toxicity is still unclear. The conformational change from a random 
coil/α-helix, soluble Aβ to a β-sheet fibrillic intermediate may be a crucial link in this 
pathogenic cascade.52;119 Small aggregates (oligomers, protofibrils)18 were reported to be 
more neurotoxic than the larger aggregates (fibrils).120 Several approaches to the 
reduction of Aβ and its associated aggregates are under development.121 Challenges of 
quantifying heterogeneous protein mixtures are key limitations of existing techniques. 
Regardless of whether protofibrils or fibrils are responsible, it is certain that there is a 
need for additional biophysical techniques to help solve this problem. 
 The main aim of this research was to apply new biophysical tools to characterize 
the Aβ peptide aggregates and to test the behavior of the peptide in the presence of 
mediators. Novel peptide-based mediators containing α,α-disubstituted amino acids 
(ααAA), dipropyl glycine (Dpg), diisobutylglycine (Dibg) and dibenzyl glycine (Dbg) 
were incorporated at alternating positions in peptide sequences forming the hydrophobic 
core (KLVFF) of Aβ. These mediators, referred to as Amy1, Amy2 and modified-Amy 
were designed with the idea that they would block amyloid fibril formation. 
 The observation that Aβ can bind a peptide fragment corresponding to the central 
hydrophobic region of Aβ (16-20) and disrupt fibril formation122;123 underlies several 
competing research efforts, including those mentioned above. Due to its ability to bind 
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and prevent amyloid fibril formation without forming fibrils itself, the KLVFF fragment 
of Aβ has been termed the ‘recognition element’. Several groups subsequently developed 
inhibitor peptides with this recognition element and an additional ‘disrupter’ group to 
either block hydrogen bonding or solubilize any Aβ-inhibitor byproduct. Soto et al.124;125 
included proline residues (known β-sheet breakers) within the recognition element and 
reported that the compound was able to prevent fibril formation, as well as partially 
disaggregate preformed fibrils. Murphy et al.38;126 designed peptides with the sequence 
(15-25) as the recognition element with the addition of hydrophilic poly(Lys) units as the 
disrupting groups. They reported that their compounds were able to alter Aβ aggregation 
by increasing the rate of protofibril assembly as well as blocked toxicity in vitro. 
Meredith et al.127 designed inhibitors that contained N-methyl amino acids, and those that 
replaced amide bonds with ester bonds in alternating positions within the recognition 
element. They found that their compounds both blocked fibril formation and 
disassembled preformed fibrils. It can be concluded that compounds containing both the 
recognition element and disrupting groups are capable of altering Aβ aggregation kinetics 
and morphology. 
 The ααAA-containing mediators were designed using Murphy’s inhibitors model 
as a template. Previous work128-130 showed that ααAA had the ability to stabilize extended 
peptide structural conformations. Fu et al.131 showed that peptides containing the Dbzg 
residues at alternating positions were capable of adopting an extended conformation, 
thereby preventing β-sheet formation. The peptide sequences of the Amy mediators are 
shown in Scheme 1 below. Complete synthetic protocol of the Amy mediators has been 
described.132;133 
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Scheme 2: Code name and sequence of modified ‘recognition element’ peptide blockers 
of Aβ assembly 
 
MURPHY: H-Lys-Leu-Val-Phe-Phe-Ala-(Lys)6-NH2 
MEREDITH : H-Lys-Leu(Me)-Val-Phe(Me)-Phe-Ala(Me)-Glu-NH2 
 
 A combination of techniques was used to determine the stability of Aβ peptide 
and kinetics of fibril growth in an attempt to identify the early and intermediate stages of 
assembly. Physiological factors that induce the aggregation of soluble Aβ are of interest 
in determining the cause of Aβ fibril formation.134 It is known that the peptide tends to 
self-assemble under conditions of low and neutral pH (as a function of time). The peptide 
remains in a monomeric or low oligomeric state at high pH values. The effect of variables 
including concentration, ionic strength, pH and temperature were monitored. 
Subsequently, the interaction of ααAA-containing peptide blockers with Aβ was tested.  
5.2 Materials and Methods 
• Reagents and Chemicals 
For this study, synthetic β-amyloid(1-40) and fluorescently labeled β-amyloid(1-
40) were obtained from Anaspec, Inc. San Jose, CA (catalog #’s 20698 and 23513).  
Phosphoric acid (99.999%, Catalog No. 34,524-5) and semiconductor-grade potassium 
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hydroxide (99.99%, Catalog No. 30,656-8) were obtained from Aldrich Chemical Co. 
Sodium chloride (99.999%, Catalog No. 10862) was obtained from Alfa Aesar.  The 
filters used were from Whatman, 0.02 µm (Anotop 10, Catalog No. 6809-1102). 
• Sample Preparation 
The biggest challenge in preparing β-amyloid samples is controlling the initial, 
unaggregated state of the peptide.  This is particularly important in order to understand 
the early stages of amyloid aggregate formation.  The presence of ‘seeds’ was reported to 
greatly accelerate the aggregation of Aβ.54 To circumvent this problem, stock solutions 
were prepared by dissolving the Aβ peptide in 10 mM aqueous potassium hydroxide.  
This initial step was important as environments of high pH was found to produce ‘stable’ 
solutions of Aβ.87 The word ‘stable’ is taken to mean, not immediately forming 
protofibrils when subjected to physiological phosphate buffer conditions; in other words, 
the sample should be ‘non-aggregating’ for weeks.  
Stock solution (500 µM) was prepared by dissolving the peptide in 10 mM 
potassium hydroxide and vortexing until completely dissolved.  In those instances where 
the sample was difficult to solubilize, it was sonicated in a Branson Model No. 2510 
sonicator.  The sonication was done in five seconds cycles to prevent heat from affecting 
the sample.  An aliquot (20 µl) was removed for AAA and the remaining solution was 
filtered through a 0.02 µm Whatman Anotop filter.  Following filtration, an aliquot was 
removed for AAA.   A 10X phosphate-buffered saline (PBS), pH 7.4 (0.5 M phosphoric 
acid, 1.5 M sodium chloride, 5 M potassium hydroxide) was filtered through 0.2 µm 
Whatman Anotop filter, after which it was mixed with the desired volume of stock to 
make final solutions of desired peptide concentration in 1X PBS, pH 7.4. Note that water 
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was first added to the peptide filtrate prior to adding the desired amount of PBS needed 
for 50 mM, in order to prevent rapid disruption of sample in such high ionic strength.  
Dilute solutions were made by adding buffer to the stock solution.  The samples were 
loaded in 0.2-mm-path-length rectangular microslides (VitroCom) by capillarity, and the 
microslides were flame-sealed.    
5.3 Results 
5.3.1 Solution Properties of β-amyloid Peptide 
• Effect of variables on Aβ peptide aggregation 
 The application of fluorescence photobleaching recovery (FPR) and dynamic light 
scattering techniques to the Aβ protein aggregation process are presented. In the case of 
Aβ, it has been shown that labeling exclusively at the N-terminus of the peptide 
minimizes modifications to the peptide conformation caused by the fluorophore’s 
presence and preserves the original biological activity.135;136 The first experiment was to 
determine the effect of varying bleaching time on the diffusion values of a solution 
composed of 5-carboxyfluorescein labeled Aβ and mixtures of 5-carboxyfluorescein 
labeled Aβ with unlabeled Aβ peptide. Figure 5.1 shows the diffusion coefficient as a 
function of increasing bleach time at a laser power of 0.5 Watts.  Both a plot for a 100% 
labeled peptide and a  25/75 ratio labeled to unlabeled peptide at a concentration of 50 
µM dissolved in 50 mM PBS, 150 mM NaCl, pH 7.4 are displayed. There is a slight 
difference in the diffusion coefficient values obtained for the two samples; however, both 
display decreasing diffusion coefficient values as a function of increasing bleach time. At 
bleach times up to two seconds, the 100% labeled sample has slightly bigger diffusion 
values than the mixed (25/75 ratio labeled to unlabeled peptide) sample, except at the 
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highest bleach time of three seconds, where it is slightly smaller. It is evident (25% 
difference in diffusion coefficient values from the initial bleach at 0.5 s to final bleach 
time of 3.0 s) in the results that the increasing bleach times is causing changes to the 
sample, however, it is difficult to attribute the decreasing trend in the diffusion values to 
degradation of the samples due to heating by the laser. If cleavage of the fluorophore 
occurred, then faster diffusion values representative of free dye would have been 
expected. The smaller diffusion values suggest that some sort of binding or Aβ peptide 
interaction may be more likely. These results indicate that care should be taken to avoid 
high bleaching times as this affects the diffusion values of the peptide.  
Figure 5.2, top and bottom shows a screen capture of the raw FPR data for the 
100% labeled peptide (at the conditions above) bleached for 3.0 s (top) and 0.5 s 
(bottom). Both conditions produced reliable diffusion coefficients. The arrow in each 
figure demonstrates the DC signal before and immediately after the bleaching pulse. In 
the top figure, about 50% of the sample is bleached and less than 10% in the bottom 
figure. In the orginal and most common form of doing FPR experiments, very deep 
bleaching (exceeding 50%) of a circular or Gaussian spot are required. In most of those 
studies the samples measured are typically live cells or proteins. Apparently sample 
damage due to prolong laser beam exposure has not hindered the use of this method. The 
lack of defined boundary conditions for diffusion in Spot photobleaching may give rise to 
partial photobleaching recovery. In heterogeneous samples where multiple diffusers are 
present, the possibility that slow and fast diffusers may exchange on the same time scale 
is highly likely and problematic. Shallow bleaches, typical 5-10% are sufficient in the 
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modulation detector FPR system and this method is well-suited for analyzing 
polydisperse systems. 





 100% Labeled Aβ1-40 [50 µM]











Figure 5.1 Diffusion as a function of bleach time of labeled and mixture of labeled and 
unlabeled Aβ. The filled square symbol represents 100% 5-carboxyfluorescein Aβ1-40 and 
the open circle symbol represents a mixture of 25% 5-carboxyfluorescein Aβ1-40 with 
75% Aβ1-40 expressed as percentage of 50 µM peptide. Conditions: 50 mM PBS, 150 mM 
NaCl, pH 7.4; laser power, 0.5 Watts.  Error bars are standard deviations from triplicate 
runs.   
 
 
The effect of bleach time on the diffusion of Aβ peptide established that over-
heating during the photobleaching pulse may have potentially caused changes to the 
overall sample integrity and caution should be taken to avoid over-bleaching. Next, the 
effect of a fluorophore’s presence on the Aβ peptides’ normal property was examined. 
Samples were prepared having different ratios of 5-carboxyfluorescein labeled to 
unlabeled Aβ1-40.   




Figure 5.2 Representative raw FPR data for 100% 5-carboxyfluorescein labeled Aβ 
bleached at 3.0 s and 0.5 s respectively. The x-axis is time and the y-axis is the contrast 
(signal amplitude) for all plots. The arrows indicate the pre and post-bleach DC signal. 
(A) Linear-Linear scale representation. (B) Information about the sample file. (C) 
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These samples were measured and compared to 100% labeled Aβ1-40 as a test that 
attachment of a probe had little effect on the sample properties. Figure 5.3 shows the 
diffusion coefficient of the 100% labeled sample was within error of that measured in the 
mixed samples, indicating that the dye moiety does not itself preferentially interact with 
unlabeled Aβ1-40 molecules. In the studies done with a mixture of labeled and unlabeled 
Aβ1-40 peptide, a ratio of one to three or twenty-five to seventy-five percent labeled to 
unlabeled peptide was used, mostly to compensate for any given strength of the laser 
power. If a protein is purchased fully labeled, cutting in some unlabeled material may 
prove useful98 and practical if the labeled peptide is three times as costly as the unlabeled 
peptide. 















Figure 5.3 Diffusion as a function of dyed to undyed Aβ, expressed as percentage of 50 
µM 5-carboxyfluorescein Aβ1-40 mixed with 50 µM Aβ1-40 Conditions: 50 mM PBS, 150 
mM NaCl, pH 7.4.  Error bars are standard deviations from triplicate runs.   
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• Effect of Concentration on Aβ Assembly 
 
The kinetics of Aβ aggregation are known to depend on the peptide concentration, 
pH and ionic strength.137-141  In addition, negligence in sample preparation such as 
impurities in the sample containers, surface roughness of sample containers,  
introduction of salt, metal ions, and contact with metals can all induce aggregation.87 
The effect of concentration on the diffusion coefficient of Aβ samples was examined. 
Figure 5.4 shows the effect of increasing concentration on the diffusion coefficient of 
75/25 % labeled to unlabeled Aβ peptide in 10 mM KOH. The samples were 
measured on three consecutive days, stored in a dark chamber, and measured again on 
the twenty-sixth day following sample preparation. As Aβ peptide was observed to be 
non-aggregating at high pH, no concentration dependence on the diffusion coefficient 
of the peptide was expected and none was observed. 
The diffusion coefficients at each concentration and at the given times measured are 
almost identical within experimental error. The slight decrease in the diffusion coefficient 
measured on day 2 may be attributed to variation in measuring conditions, such as 
increased laser intensity or bleached time. The measurement on day 26 was done at a 
different objective setting and consequently spatial frequency value in an attempt to 
improve the signal quality. Improvement in the signal quality does not however explain 
the faster diffusion values obtained on day 26. At instances where the Aβ was bleached 
too deeply, slower diffusion values resulted, thus the most likely explanation for the 
faster diffusion values may be attributed to stabilization of the sample due to the presence 
of the 5-carboxy-fluorescein fluorophore. The dye may be hindering the Aβ peptide’s 
ability to self associate with a likely consequence being contraction of the peptide. 
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K=157 cm-1 (4x objective)












 Day 26  
 
Figure 5.4 Effect of concentration on the diffusion coefficient of 75/25 % labeled and 
unlabeled Aβ peptide. The samples were measured on three consecutive days and stored 
for a period of time and measured again on the twenty-sixth day following sample 
preparation. The filled circles represent data from day 1. The open circles represent data 
from day 2. The open upside-down triangles represent data from day 3. The filled 
triangles represent data from day 26. Conditions: 10 mM KOH, (Ronchi Ruling = 50 
lines per inch; objective = 4X, K = 157 cm-1 and objective = 7X, K= 253 cm-1). 
 
• Effect of pH and Ionic Strength on Aβ Assembly 
 
FPR measurements were made on samples containing 25% labeled and 75% unlabeled 
peptide at three pH values, spanning the range where the peptide is believed to exist in 
the high-to-low oligomeric states. Figure 5.5 shows diffusion coefficient results for a 
mixture of labeled and unlabeled Aβ (100 µM in 50 mM phosphate buffer at pH 2.7, 6.9 
and 11) over a one month period.  The diffusion values are consistent with theoretical 
predictions.63  They also match experimental values for monomeric β-amyloid1-40 
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measured elsewhere using diffusion ordered NMR spectroscopy.62  These results 
demonstrate that attachment of a dye does not radically alter the hydrodynamic size of the 
peptide; however, these findings are perplexing as the β-amyloid1-40 peptide is widely 
thought to aggregate at neutral and lower pH values.  Smaller values of diffusion 
coefficient might have been expected as the Aβ1-40 peptide was thought to aggregate 
within the experimental time frame at neutral pH.  One possibility is that the 5-carboxy 
fluorescein dye attached to the peptide is contributing to its stability.  Figure 5.6 shows 
the corresponding semilogarithmic plot for representative data demonstrating almost 
single exponential characteristic of a monodisperse sample. 





























Figure 5.5 Trend of pH effects on the diffusion coefficient of Aβ. Conditions: sample was 
composed of a 100 µM 25/75 % mixture of labeled and unlabeled Aβ in 50 mM PBS, 150 
mM NaCl at pH ► 2.7, ○ 6.9, and ■ 11. The error bars are standard deviation of triplicate 
runs. 
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In order to further explore possible explanations for the results in Figure 5.5, it 
was necessary to perform additional experiments. While repeating the experiment with a 
fresh stock of peptide would have been best (that was done and those results are 
discussed below), it was simpler to verify that the peptide was capable of assembling by 
varying a condition known to induce aggregation. One such condition is the presence of 
high concentrations of salts in the aqueous solution.142 FPR measurements were made on 
100 µM Aβ samples containing 25% labeled and 75% unlabeled peptide in different 
concentrations of sodium chloride environments. The effect of added sodium chloride on 
the diffusion coefficient of the Aβ sample was monitored. At low salt concentrations, 
only one decay mode was observed.  





















Figure 5.6 Semilogarithmic FPR traces for three Aβ samples at different pH values. After 
baseline subtraction, each semilogarithmic representation highlights the almost single exponential 
characteristic of a monodisperse sample. Conditions: 100 µM 25/75 % mixture of 5-
carboxyfluorescein Aβ and unlabeled Aβ in 50 mM PBS, 150 mM NaCl at pH values ► 
2.7, ○ 6.9, and ■ 11.  
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At ionic strengths of 100 µM up to a sodium chloride concentration of 200 µM, double 
exponential behavior was observed.  Subsequently, the effect of pH on Aβ aggregation 
experiment was repeated using a fresh batch of only labeled Aβ. 




















Figure 5.7 FPR measurements on samples containing 100% 5-carboxyfluorescein-labeled 
peptide in 50 mM PB, at pH 7.4 with increasing sodium chloride concentrations.  The 
monomeric diffusion coefficient of Aβ(1-40) was found to be 1.58 x 10-6 cm2s-1.  
 
 
 In Figure 5.8 are shown results for labeled Aβ1-40 peptide at three different pH 
values (► 2.7, ○ 6.9, and ■ 11).  The diffusion coefficient values at pH 6.7 and 11 were 
almost identical, (as observed in Figure 5.5 with the mixed Aβ sample), and remained 
constant over a period of two weeks. At pH 2.7, the diffusion coefficient did decrease 
significantly with time.  When this result is converted to diameter via the Stokes-Einstein 
equation (Dh = kT/6πηR, where η represents the viscosity), one finds an enormous 
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increase in hydrodynamic diameter from about 2.6 nm to about 860 nm.  This observation 
correctly indicates the ability of FPR to follow a very wide range of diffusers.  The 
decreases in diffusion in Figure 5.8 do not fully reflect the presence of macroscopically 
large aggregates that were visible immediately after lowering the pH.   



















Figure 5.8 Diffusion of 100 µM 5-carboxyfluorescein Aβ1-40 (100% labeled) in 50 mM 
PBS, 150 mM NaCl, pH values, ► 2.7, ○ 6.9, and ■ 11.  Error bars are standard 
deviation of triplicate runs. 
 
A fluorescence microscopy image of the aggregated peptide (100 µM 5-
carboxyfluorescein Aβ1-40, 50 mM PBS, 150 mM NaCl, pH 2.7), is shown in Figure 5.9a, 
accompanied by an image of the stripe pattern in Figure 5.9b.  Visible aggregates are 
present throughout, but they are not uniformly distributed; thus, the measured diffusion 
can vary within the sample cell, depending a little on the position chosen for 
measurement.  One advantage of FPR is that one may choose visually to measure regions 
that do not possess extraordinarily large aggregates.  If the striped pattern were to 
illuminate regions with many of these very large aggregates, the recovery of the signal 
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would be incomplete on the time scale of observations in this study.  Very long 
observations might then reveal the rate of exchange of molecules into and out of the very 












Figure 5.9 (a) Fluorescence microscopy image of 100 µM 5-carboxyfluorescein Aβ1-40 in 
50 mM PBS, 150 mM NaCl, pH 2.7. (b) microscopy image of Ronchi ruling stripe 
pattern in labeled gelatin.   
 
The log-log curves of Figure 5.10a, demonstrate the effectiveness of FPR as a tool 
to detect simultaneously both the large, slow diffusers and the small, fast ones within a 
given sample.  Over 99% of the contrast was relaxed in these measurements, indicating 
that immobile fragments were avoided.  Even in cases where a large fragment is 
illuminated, such that the recovery levels out after some time, it is possible to determine 
the size of the mobile fraction by treating the immobile fraction as a baseline term during 
analysis.  
Further analysis of the data curves in Figure 5.10a, was done by estimating the 
inverse Laplace transform, ILT, using an adaptation of Provencher’s143;144 CONTIN 
program. The corresponding CONTIN distributions of the data are shown in Figure 
5.10b.  
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Figure 5.10 (a) Log-log FPR traces for Aβ samples at three pH values. After baseline 
subtraction, each semilogarithmic representation highlights double exponentiality 
characteristic of a polydisperse sample. Conditions: 100 µM 25/75 % mixture of 5-
carboxyfluorescein Aβ and unlabeled Aβ in 50 mM PBS, 150 mM NaCl at pH values ► 
2.7, ○ 6.9, and ■ 11. (b) CONTIN distributions of data in (a).               (figure continued) 
(a) 
(b)  







Figure 5.10 (continued) (c), (d), screen capture of the overlay of data, multiple 
exponentials and CONTIN. The roman numerals indicate: (I) simulated diffusion data, 
(II) ILT from CONTIN, (III) exponential analysis, (IV) error in CONTIN amplitude, (V) 
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Figure 5.10 (continued) (e), screen capture of the overlay of data, multiple exponentials 
and CONTIN. 
 
The major peak at pH 11 indicates that the majority of the diffusing species are 
narrowly distributed. The major peaks corresponding to pH 2.7 and 6.9, demonstrates 
slightly broader peaks than that of pH 11, with one (pH 6.9) and two (pH 2.7) additional 
smaller peaks. The broader peak represents the diffusion of the fast molecules, while the 
smaller peaks are assigned to the slowly diffusing species. The well-defined CONTIN 
peaks were an indication of the size range of the various species in solution. These results 
indicate that each pH environment induced different aggregation properties of the Aβ 
peptide. 
Figure 5.10 (c), (d), and (e) displays CONTIN fits with compressed data and 
overlaid exponential fits corresponding to the decay behavior of single (c, pH 11) and 
multiple diffusers (d, pH 6.9, and e, 2.7). In Figure 5.10c, for the single diffusing species 
at pH 11, the average decay rate obtained by the ILT agreed with the single exponential 
(e) 
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result (indicated by magenta vertical line dissecting the major peak). A fast diffuser with 
narrow distribtution and large error bars is evident in both Figure 5.10c and d. This can 
be attributed to failure of the beginning data points to follow the trend in the exponential 
analysis.  In Figure 5.10d, the fast decay mode of the ILT distribution failed to overlay 
with the results from triple exponential analysis. This suggests that a double exponential 
analysis would fit the data best. In Figure 5.10e, almost perfect agreement between the 
overlay of the ILT and triple exponential analysis is demonstrated. 














 Single Exponential - Fast
 Double Exponential - Slow
 
 
Figure 5.11 Effect of temperature on the aggregation properties of Aβ peptide. 
Conditions: 100 µM Aβ in a 100 mM PBS, 150 mM NaCl, pH 7.4. 
 
• Effect of Temperature on Aβ Assembly 
 
 The effect of temperature on Aβ assembly was also investigated. Figure 5.11 
shows the response in diffusion coefficient values as a function of increasing 
temperature. The high temperature was expected to induce the self-assembly of the Aβ 
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peptide. The results indicate that only a fast and slowly diffusing species were present 
from the initial physiological temperature, and the duration of the experiment.  
The trend in the diffusion coefficient implies that perhaps the Aβ sample had stabilized 
and the increasing temperature did not affect the structural integrity of the peptide. 
 
5.3.2 Development of a Convenient Tool to Study β-amyloid Assembly   
 
• Dialysis fluorescence photobleaching recovery 
 
It was demonstrated that FPR was able to successfully characterize Aβ peptide. 
The sensitivity of this technique made it possible to distinguish between the sizes of 
several species in a heterogeneous solution. To further improve the economy of 
experimenting with the expensive ($640/mg) 5-carboxyfluorescein (labeled) Aβ and to 
test the efficacy of mediator peptides, an in situ FPR dialysis cell was developed.145 The 
advantages of this set-up include simplified studies on the effect of salt and pH on Aβ 
aggregation, as well as addressing the reversibility of the peptide in solution.  
A schematic of the constructed dialysis FPR cell is shown in Figure 5.12. The 
housing (a top cover and a bottom chamber) of the cell was fabricated from PTFE. A 
mini peristaltic pump (Crouzet, France) with a motor speed of 60 rpm was used to 
circulate the exchange fluid through the subchamber from a 250 mL filter flask at a rate 
of about 20 mL/min. The microscope viewing piece was constructed with round 
microscope cover glass that was bonded for about 24 h at room temperature, under 
modest pressure, to an etched Teflon sheet with a thickness of 0.3 mm (Small Parts, Inc.) 
using Super Glue (a fast-curing cyanoacrylate formulation, Walmart). The dialysis 
membrane (Spectrum® Laboratories Inc. Spectra/Por #7) that forms the semi-permeable 
partition between the sample and exchange fluid had a 2000 Da MWCO. To prepare the 
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set-up, typically 250 µL of sample is sandwiched between the microscope viewing piece 
and the dialysis membrane. The inside of the bottom chamber (area underneath the 
dialysis membrane) is filled with 15 mL of the exchange fluid. When the dialysis housing 
is closed, the dialysis membrane is pressed against the etched Teflon space and in turn 
against the cover glass and the bottom chamber, using O-rings. The large dialysis area (~ 











                              
Figure 5.12 Schematic and photograph of the dialysis FPR cell. 
Cover slip 
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 The kinetics of Aβ aggregation was monitored by dialyzing 50 µM of labeled Aβ 
sample against 10 mM citrate buffer at pH 5.0. The sample was initially solubilized in 10 
mM KOH. Figure 5.13 shows the slow decline in diffusivity of Aβ under exposure to the 
weak citrate buffer. After about 1 hr, a slow diffuser appears, representing assemblies 
with a hydrodynamic radius of about 23 nm. This larger species, which accounted for 
about 18% of the Aβ present, would have been expected to grow to many times larger in 
time. This growth was not observed due to a problem with the dialysis cell. The problem 
commonly encountered is that the microscope cover glass tends to crack with prolonged 
dialysis. This may be attributed to the fragility of the glass or perhaps as a result of 
changes in the pressure of the system.     


















Figure 5.13 Evolution of protofibrils from labeled monomer after dialysis against a weak 
citrate buffer at pH 5.0. After ~ 1hr, large aggregates appear and represent about 18% of 
the signal. 
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 The dialysis of Aβ against citrate buffer demonstrated that it was possible to 
change the size of the peptide in a relatively short period of time. Thus, an alternate 
buffer in which the aggregation of the peptide was ‘delayed’ or rather, representative of 
typical growth kinetics of the peptide (where rapid aggregation was not induced) was 
desired. To achieve this, a new sample, composed of 50 µM labeled Aβ in 10 mM KOH 
was dialyzed against 100 µM Acetate buffer at pH 4.0. Figure 5.14 shows the time 
response of the diffusion coefficient of the peptide after first dialyzing against acetate 
buffer, followed by the addition of increasing concentrations of calcium chloride, 0.1 N 
HCl, and finally 50 mM phosphate buffer, pH 7.2. Both fast and slow diffusers were 
present after about 30 mins of sample dialysis.  This was indicated by the biexponential 
analysis of the data. There was a slight decrease in the diffusion coefficient values, but, 
after 19 hrs of dialysis, the diffusion coefficient was almost identical within experimental 
error, to the initial diffusion coefficient value. The trend in the diffusion coefficient 
suggested that the aggregates had stabilized; otherwise the diffusion values would have 
been expected to continue to decrease after the first 5 hrs of dialyzing. At this point, it 
was best to change the course of the experiment.   
Several choices were possible, but the effect of calcium chloride on the Aβ 
species present in solution was investigated. The required amount of CaCl2 corresponding 
to 5 mM was added to the dialysis fluid and the sample was dialyzed for about 1 hr. The 
diffusion coefficient response remained biexponential and decreased with increasing 
calcium chloride concentration, up to 15 mM. After addition of 25 mM calcium chloride 
to the dialysis fluid, the diffusion coefficient remained almost identical to that obtained 
for 15 mM. The sample was dialyzed for an additional 2 hrs and measured again. The 
 68  
diffusion coefficient value increased slightly higher than that obtained with 15 mM 
CaCl2, but overall, still smaller than when the sample was dialyzed against acetate buffer. 
The addition of CaCl2 (up to 15 mM) facilitated the aggregation of Aβ. Additional CaCl2 
(up to 25 mM), suppressed this effect and appeared to instead dissociate the Aβ 
aggregates. The reason for this is not obvious but can be explained as a change in the pH 
of the dialyzing solution due to the addition of calcium chloride. It can be proposed that 
calcium chloride binds certain amino acid residues in the Aβ peptide. Increasing the 
calcium chloride concentration may have created slightly acidic pH conditions which 
perhaps destabilized the aggregates. This can be compared to the effect of the divalent 
metal Zn(II) on Aβ aggregation. Zn(II) was found to promote Aβ aggregation at normal 
pH while suppressing Aβ aggregation at slightly acidic pH conditions.146 At this point in 
the experiment it appeared that the formation of aggregates was sequestering the 
fluorophore. This was evident by a significant loss of fluorescence in the sample and the 
appearance of black (non-fluorescent) aggregates. One explanation why the sample had 
become difficult to bleach may simply be that with extensive dialysis, any source of 
oxygen present in the sample had become depleted. The pH of the sample was adjusted 
with 0.1 N HCl, to a final pH of about 1. The sample was dialyzed for almost 17 hrs and 
subsequently measured. The sample had regained full fluorescence intensity and 
apparently the biexponential nature had disappeared and the diffusion coefficient was 
now a single exponential value. The dialysis fluid was then exchanged with 50 mM 
phosphate buffer, pH 7.2. The diffusion coefficient remained single exponential and 
increased to a value higher than that of the 0.1 N HCl.  
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Figure 5.14 One Pot dialysis of 50 µM 5-carboxyfluorescein labeled Aβ starting at pH 11, 
then dialyzing against 100 µM acetate buffer, pH 4, increasing concentrations of calcium 
chloride, 0.1 N HCl and 50 mM phosphate buffer, pH 7.2. 
 
The percent amplitude corresponding to each biexponential point plotted in Figure 
5.14 is displayed in Figure 5.15. Since each point represent an average of triplicate runs, 
the signal amplitude of each individual run was plotted. It appeared that the larger species 
were dominant in solution and represented about 75% of the sample. This value 
fluctuated slightly between 60% and 75% when the sample was dialyzed for a period of 
time in acetate buffer. Since different regions within the sample were chosen for 
measurement, the variation in the signal amplitude suggests that different species were 
present. This variation may also indicate that perhaps some regions within the cell 
experienced more perturbation from the pulsating action of the dialysis fluid circulating 
through the subchamber. This experiment showed the potential of the in situ dialysis cell 
to vary pH in small steps and also follow the changes from the addition of salt. If one 
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considers the variation of pH environments that proteins encounter within the cell, then 
the in situ dialysis cell may be able to simulate such cellular environments to provide 
information about the structural changes of a proteins’ passage through such changing 
environments.  






















 Slow  
 
Figure 5.15 Percent amplitude of fast and slow components of FPR diffusion coefficient 
values in Figure 5.14.  
 
The reversibility of Aβ aggregation through pH changes was studied by 
alternating the pH within the dialysis cell. First, the effect of pH on the diffusion 
coefficient of labeled Aβ, without addition of unlabeled material was monitored. Figure 
5.16 shows the diffusion coefficient of 100 µM labeled Aβ initially dissolved in 10 mM 
KOH alternately dialyzed against 50 mM PB, pH 2.7, and 50 mM PB, pH 7.2. Since the 
system is dilute, the diffusion coefficient can be converted to a hydrodynamic radius 
through Stokes’ law. The hydrodynamic radius of the peptide at pH 7.2 is about 1.5 nm, 
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typical of monomeric Aβ peptide. At pH 2.7, the formation of protofibrils resulted in 
decreased diffusion coefficient, corresponding to a hydrodynamic radius of about 90 nm. 
The sample was then dialyzed back against the phosphate buffer at pH 7.2. The diffusion 
coefficient rose to the starting value. After periodically measuring the diffusion 
coefficient while the sample was being dialyzed, for about 15 hrs, there was no 
significant change in the diffusion coefficient value. The sample was not dialyzed back 
against low pH as the microscope cover glass broke. The same experiment was repeated 
with an alternate sample that contained unlabeled Aβ peptide. 






Dialysis against 50 mM PB, pH 2.7











Figure 5.16 Diffusion from in situ FPR of 50 µM 5-carboxyfluorescein-Aβ starting at pH 
11, then alternately dialyzed between pH 2.7 and pH 7.4.   
 
Figure 5.17 shows the time response of the diffusion coefficient of 100 µM 5-
carboxyfluorescein-Aβ (25% mixed with unlabeled 75% Aβ), starting at pH 11 and 
alternately dialyzed against 50 mM phosphate buffer, pH 2.7 and 50 mM phosphate 
buffer, pH 7.4. The trend in the diffusion coefficient was similar to that obtained for the 
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labeled Aβ peptide in Figure 5.16. The diffusion coefficient was converted to 
hydrodynamic radius and at pH 7.4 the Aβ had a hydrodynamic radius of about 1.5 nm. 
At the lower pH, 2.7, the hydrodynamic radius was 85 nm at the first cycle and decreased 
to 46 nm on the second. Additional studies were done to determine the aggregation limit 
of the Aβ peptide through dialysis. When the Aβ peptide was extensively dialyzed for a 
week at pH 7.4, the diffusion coefficient started and remained stabilized at the same value 
(1.75 × 10-6 cm2s-1) representative of a monomeric Aβ peptide. 
















Figure 5.17 Diffusion from in situ FPR of 100 µM 5-carboxyfluorescein-Aβ (25% mixed 
with unlabeled 75% Aβ) starting at pH 11, then alternately dialyzed between pH 2.7 and 
pH 7.4.   
 
5.3.3 Interaction of Aβ Peptide with Peptide Mediators  
 
• Non-fibril forming Accelerators 
 
 The hydrophobic core, KLVFF, of the Aβ peptide has been used by several 
researchers to design inhibitors of Aβ aggregation and dissolution of pre-formed fibrils. 
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Peptides containing alpha-alpha disubstituted amino acids (ααAA) were designed and 
prepared at LSU as potential inhibitors of Aβ fibril formation. The Murphy and Meredith 
peptides (designed by Regina M. Murphy at University of Wisconsin and Stephen C. 
Meredith at the University of Chicago, respectively) were also prepared at LSU and used 
as control. FPR was used to identify mechanistic differences in how the different 
mediator peptides interact with Aβ. Samples were prepared at a 1:1 ratio with 100 µM 5-
carboxy-fluorescein Aβ and mediator peptides in 50 mM PBS, 150 mM NaCl, pH 7.4. A 
sample composed of 100 µM 5-carboxy-fluorescein Aβ and a mixture of 5-carboxy-
fluorescein Aβ with unlabeled Aβ peptide was also measured for comparison. Figure 5.18 
shows the diffusion coefficient as a function of time for 5-carboxy-fluorescein Aβ and 
mediator peptides: Amy1, Amy2, Modified Amy, Murphy, and Meredith. The diffusion 
coefficient of all the Aβ and mediator peptide mixtures tended to decrease after fifteen 
hours of sample preparation, with the exception of fluorescein-Aβ: Amy1 which seemed 
to maintain a constant diffusion coefficient value for the duration of the experiment. The 
sample mixture of 5-carboxy-fluorescein Aβ and unlabeled peptide had the fastest 
diffusion coefficient values while the fluorescein Aβ: Modified Amy mixture had the 
lowest diffusion coefficient value overall. These results are an early indication that the 
mediator peptides all have different modes of interaction with the Aβ peptide. The results 
mostly seem to indicate that the mode of inhibition may not involve shrinkage of the Aβ 
peptide, as the decreasing trend in the diffusion coefficient values implies increasing 
particle size. The diffusion coefficient results of the mixture of 5-carboxy-fluorescein Aβ 
and unlabeled peptide is a bit perplexing as the 5-carboxy-fluorescein Aβ would have 
been expected to have the fastest diffusion coefficients. Perhaps, the unlabeled peptide is 
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causing the 5-carboxy-fluorescein Aβ to collapse on itself, becoming smaller as a result. 
Another explanation might be that the unlabeled Aβ peptide repels the 5-carboxy-
fluorescein Aβ molecules, making them freer to move in solution. Whatever the scenario, 
the diffusion coefficient results are indicative of small molecules with increased mobility. 
The results from FPR studies on the interaction of Aβ with mediator peptides 
indicated that the 5-carboxy-fluorescein labeled Aβ peptide could track changes in the Aβ 
peptide aggregation kinetics in the presence of peptide-based mediators. Thus, the 
question of whether the labeled Aβ peptide could be substituted for Thioflavin T (ThT) as 
an alternate means of monitoring fibril growth or disassembly was addressed.  


































Figure 5.18 Diffusion coefficients of Aβ and peptide-based mediators as a function of 
time. Conditions: 100 µM 5-carboxy-fluorescein labeled Aβ and 100 µM 5-carboxy-
fluorescein labeled Aβ with 100 µM: Amy1, Amy2, Modified Amy, Murphy, and 
Meredith in 50 mM PBS, 150 mM NaCl, pH 7.4. 
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Thioflavin T is a fluorescence probe that exhibits enhanced fluorescent properties 
upon binding to amyloid fibrils.147 Several studies have utilized ThT fluorescence for 
monitoring Aβ kinetics.28;148;149 While ThT fluorescence is a highly sensitive probe for 
detecting fibril formation, its earliest binding activity has been reported to commence 
with the oligomeric form of the Aβ peptide.138;147 Perhaps, the 5-carboxy-fluorescein 
labeled Aβ peptide would be able to detect even earlier stages of Aβ aggregation and 
therefore eliminate the need for ThT.  Ultimately, it could be used for screening the 
efficacy of Aβ mediators. Fluorescence spectroscopy, using 5-carboxy-fluorescein 
labeled Aβ as the probe, was used to monitor the kinetics of amyloid fibril formation and 
the effect of peptide mediators on Aβ aggregation. FPR measurements were done on the 
same samples for quantitative assessment of the data. 
Initial fluorescence spectroscopy experiments were done with different 
concentrations of the 5-carboxy-fluorescein labeled Aβ and mixtures with unlabeled 
peptide to determine the optimal concentration whereby the sensitivity limit of the 
detector would not be exceeded. Subsequently, a series of samples were prepared by 
diluting appropriate concentrations of Aβ peptide and peptide-based mediator stock 
solutions directly (to take advantage of its high-throughput capabilities) into a 96-well 
plate for fluorescence spectroscopy measurements. Aliquots of the same samples were 
loaded in 0.1-mm-path-length rectangular microslides (Vitrocom) by capillary action, and 
the microslides were flame-sealed for FPR measurements.  
The fluorescence spectroscopy results had no meaningful interpretation. A screen 
capture of the results plotted in real time in an Excel spreadsheet by the FLUOstar 
Galaxy software is shown in Appendix A. A table showing a 96-well plate layout with 
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the corresponding sample identification is also shown in Appendix A. While the 96-well 
plate is highly efficient for fluorescence spectroscopy, it proved a rather daunting task to 
perform the FPR experiment with all the samples on the same day. Table 5.1 summarizes 
the diffusion coefficient results for Aβ and Aβ in the presence of various peptide 
mediators obtained by FPR. The LAβ samples are composed of 0.1 µM 5-carboxy-
fluorescein labeled Aβ and LAβAβ represent mixtures of 0.1 µM 5-carboxy-fluorescein 
labeled Aβ and 25 µM unlabeled Aβ. The FPR results show that under physiological 
conditions (50 mM PBS, 150 mM NaCl, pH 7.4, incubated at 37 °C for one day), all the 
samples (Aβ and Aβ  mixed with peptide-based mediators) had a diffusion coefficient 
representative of a predominantly low oligomeric state (monomer-dimer in equilibrium)62 
value, with the exception of LAβAβ-Amy1 and LAβAβ-Amy2. Both the labeled Aβ and 
the mixture of labeled Aβ and unlabeled Aβ had diffusion coefficient values that were 
similar within experimental error. In subsequent experiments a mixture of labeled Aβ and 
unlabeled Aβ was chosen in an effort to limit the presence of the fluorophore and have a 
more native-peptide-like sample. The additional diffusion coefficient value for the 
LAβAβ-Amy1 peptide was only 3.5% of the single amplitude. This suggests that a very 
small amount of higher order aggregates were present in the solution. The FPR 
measurements of the LAβAβ-Amy2 sample gave diffusion coefficient values 
representative of predominantly slowly diffusing molecules, corresponding to large 
aggregates (observed visually at 18× magnification in the light microscope). The slowly 
diffusing species represented about 80% of the signal amplitude. The data for two of the 
three runs of the LAβAβ-Amy2 sample were biexponential and the third run fitted best 
with a triple exponential analysis. The significant difference in the percentage of 
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aggregates present in the LAβAβ-Amy1 and LAβAβ-Amy2 samples indicate that the 
peptides interact with Aβ via different mechanisms. It was necessary to perform 
additional measurements on fresh samples of LAβAβ-Amy1 and LAβAβ-Amy2 at 
shorter time scales to determine how quickly those aggregates formed.  
Several samples composed of different ratios of 5-carboxyfluorescein labeled Aβ, 
unlabeled Aβ and Amy2 peptide were prepared to monitor the kinetics of Aβ and Amy2 
mediator peptide assembly. Table 5.2 shows the summary of diffusion coefficient results 
for Aβ and Aβ: Amy2 peptide mediator obtained by FPR.  
Table 5.1 Summary of FPR diffusion coefficient results for 5-carboxy-fluorescein labeled 
Aβ (LAβ) and peptide-based mediators. LAβAβ represents the code name for mixtures of 
5-carboxy-fluorescein labeled Aβ and unlabeled Aβ. The error represents standard 
deviation determined by triplicate measurements of the sample. a Only one of the 
replicate runs fitted with a triple-exponential analysis. b The percent amplitude of the 
single run with triple-exponential analysis. 
 
Sample 
(50 mM PBS, 150 
mM NaCl, pH 7.4 
– incubated at 37 
°C for 1 day) 
 
Diffusion Coefficient (cm2s-1) 
(% - Average Percent Amplitude of Signal) 
0.1 µM  
LAβ 
(1.92 ± 0.193) × 10-6  
100% 
(Multiple Exponential Analysis) 
0.1:25 µM  
LAβAβ 




















(1.46 ± 0.198) × 10-6  
 
96.5% 
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There was no significant difference in the diffusion coefficient values for different ratios 
of Amy2 in the presence of 5-carboxy-fluorescein labeled Aβ. In the presence of almost 
equal molar ratios of Aβ and Amy2 mediator, the data fitted best with triple exponential 
analysis for all three runs. 
 The largest species represented about 60% of the signal amplitude, while each of 
the remaining species represented about 20% of the signal amplitude. When the molar 
ratio of the Amy2 peptide increased to 2:1 of Amy2: LAβAβ, only two exponentials were 
observed with the slower diffuser dominant at 78%. The molar ratio of Amy2 peptide 
was increased to 10:1 of Amy2: LAβAβ. At this ratio, only one diffusing species was 
observed with a diffusion coefficient value representative of monomeric Aβ. The 
interaction of Amy2 mediator with the Aβ peptide indicated that large aggregates were 
formed almost immediately upon placing the mediator in the presence of Aβ. At the 
highest molar ratio (10:1) of Amy2 to Aβ peptide, the characteristic formation of large 
aggregates was absent, indicating that the excess mediator peptide may be blocking the 
assembly of the Aβ peptide. A three dimensional, 3-D, representation of the distributions 
of the various species present is a mixture of LAβAβ: Amy2 at a ratio of 0.1:25:25 µM is 
shown in Figure 5.19. Immediately after preparing the samples, there were three species 
in solution, the largest represented the broad peak and the smallest represented the small 
peak. After one day of incubation at room temperature, the broad peak has become 
bigger, while the small and middle peaks are now represented by one small peak. Three 
days after sample preparation, only one broad peak is observed. The distribution trends 
suggest that the initial amounts of monomeric and low oligomeric peptide got depleted to 
compensate for the growth of the larger aggregates.  
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Table 5.2 Summary of FPR diffusion coefficient results for 5-carboxy-fluorescein labeled 
Aβ (LAβ) and Amy2. LAβAβ represents the code name for mixtures of 5-carboxy-
fluorescein labeled Aβ and unlabeled Aβ. The error represents standard deviation 
determined by triplicate measurements of the sample.  
Sample 
(50 mM PBS, 
150 mM NaCl, 
pH 7.4– 
incubated at 37 
°C for 1 day) 
Ratio Diffusion Coefficient (cm2s-1) 




0.1:1 (2.72 ± 1.27) × 10-8 
32% 





0.1:2 (3.74 ± 0.938) × 10-8 
27% 






0.1:1:1 (9.86 ± 1.57) × 10-8 
20.7% 
 
(1.49 ± 0.380) × 10-8 
 
17.83% 





0.1:1:2 (1.72 ± 2.06) × 10-7 
22% 











This clearly implies that Amy2 alters the rate of Aβ assembly by forming large 
aggregates. Etienne et al.150 suggested that the Amy2 mediator peptide, (oligolysine on 
the N-terminus) disrupts Aβ assembly only at the hydrophilic N-terminus of the Aβ 
peptide. When the Amy2 mediator peptide was interacted with only labeled Aβ, which 
has a 5-carboxy-fluorescein molecule attached to the N-terminus of the Aβ peptide, the 
formation of large aggregates was still observed, similar to studies done with Amy2 and 
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Aβ peptide without an attached fluorophore. This may be further validation to the claim 
that the attachment of a fluorophore does not disrupt the normal structural activity of the 
Aβ peptide or it may be an indication that the Amy2 peptide has alternate binding sites 
other than the N-terminus of the Aβ peptide.  
Similar FPR studies were done with the Amy1 mediator peptide in the presence of 
a mixture of 5-carboxy-fluorescein labeled Aβ and unlabeled Aβ (LAβAβ). Table 5.3 
summarizes the diffusion coefficient of the Amy1 mediator peptide in the presence of a 
mixture of 5-carboxy-fluorescein labeled Aβ and unlabeled Aβ at different time periods. 
The sample composition was 0.1 µM 5-carboxy-fluorescein labeled Aβ and a one to one 
molar ratio of unlabeled peptide and Amy2 mediator peptide at 25 µM, in 50 mM PBS, 
150 mM NaCl, pH 7.4. 

















Figure 5.19 3-D representation of the diffusion coefficient data from LAβAβ: Amy2 at a 
ratio of 0.1:25:25 µM. 
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 The diffusion coefficient result obtained at zero hours and eight hours were 
almost identical within experimental error. After one day of incubation at 37 °C, the 
presence of a small percentage (4%) of a larger species was observed. After three days, 
the percentage of the larger species remained almost constant with a negligible 1% 
increase in the signal amplitude on day 3.  
Table 5.3 Summary of FPR diffusion coefficient results for Amy1 in the presence of 5-
carboxy-fluorescein labeled Aβ and unlabeled Aβ (LAβAβ).  LAβAβ represents the code 
name for mixtures of 5-carboxy-fluorescein labeled Aβ with unlabeled Aβ. The error 
represents standard deviation determined by triplicate measurements of the sample.  
Sample 
(50 mM PBS, 
150 mM NaCl, 
pH 7.4– 
incubated at 37 
°C for 1 day) 
Ratio Diffusion Coefficient (cm2s-1) 





















(1.46 ± 0.198) × 10-6 
96% 






(1.61 ± 0.101) × 10-6 
96% 






(1.66 ± 0.014) × 10-6 
95% 
(1.82 ± 0.225) × 10-8 
5% 
 
Figure 5.20 shows a graphical representation of the diffusion coefficient values found in 
Table 5.3. The fast diffusers are clearly dominant throughout the experimental time 
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frame. Although the percentages of the larger diffusers are consistently low, the general 
trend in the diffusion coefficient values indicates that the sizes of these species are getting 
smaller with time. This suggests that the Amy1 mediator is disrupting the assembly of the 
Aβ to create smaller particles. 























Figure 5.20 Diffusion coefficients as a function of time for Amy1 in the presence of 5-
carboxy-fluorescein labeled Aβ and unlabeled Aβ (LAβAβ). Conditions: 0.1 µM labeled 
Aβ and a 1:1 molar ratio of unlabeled Aβ and Amy1 at 25 µM in 50 mM PBS, 150 mM 
NaCl, pH 7.4. 
 
 FPR studies were performed with all the mediator peptides (Amy1, Amy2, 
Modified Amy, Murphy, Meredith) including the addition of another potential mediator 
molecule, one-directional [9]-6 arborol. One-directional arborols ([9]-n) are amphiphilic, 
tree shaped dendrimers with nine hydroxyl groups ([9]-) forming the hydrophilic head 
and an alkyl chain as the hydrophobic moiety (n stands for the number of carbons in the 
alkyl chain; in this case, n = 6).151-153  Sun154 discovered that the arborol molecules 
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exhibited almost similar fibrillar self-assembly properties to the Aβ peptide. Could the 
shorter, one-directional [9]-6 arborol molecule interact with the Aβ peptide to inhibit the 
amyloid fibril assembly? The amphiphilic nature of the one-directional [9]-6 arborol, plus 
the fact that is has a much smaller molecular weight than most of the designed and costly 
peptide-based amyloid inhibitors are some desirable properties that makes this potential 
amyloid fibril mediator worth investigating. The structure of the one-directional 9-6 




















Figure 5.21 Structure of one-directional [9]-6 arborol. 
 
 
The diffusion coefficient values as a function of time for each mediator and Aβ 
peptide combinations are shown. For the purpose of clarity, the data is presented as 
individual plots for each sample. Figure 5.22 shows the diffusion behavior of 10 µM 5-
carboxy-fluorescein Aβ as a function of time. For a period of one week the diffusion 
coefficient remained at an almost constant value with a slight decrease at days 5 and 7. 
The diffusion coefficient was representative of values for monomeric Aβ (refer also to 
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Figure 5.5). Figure 5.23 shows the diffusion behavior of 10 µM 5-carboxy-fluorescein Aβ 
mixed with 25 µM unlabeled Aβ as a function of time. For the first three days the 
diffusion coefficient remained at an almost constant value, characteristic of the ‘lag 
phase’ that precedes fibril growth. At days 5 and 7, the presence of larger aggregates was 
observed. 



















Figure 5.22 Diffusion coefficients as a function of time for 5-carboxy-fluorescein Aβ (5-
CF-Aβ). Conditions: 10 µM 5-carboxy-fluorescein Aβ was prepared in 50 mM PBS, 150 
mM NaCl, pH 7.4. 
 
Initially, the larger species represented only 2 % of the signal amplitude, but by 
the seventh day, that value had increased dramatically to 32%. This demonstrates the 
‘seeding’ effect of the Aβ. The presence of small amounts of seeds was sufficient to 
initiate Aβ peptide assembly. 
Figure 5.24 shows the diffusion behavior of 10 µM 5-carboxy-fluorescein Aβ and 
a one-to-one molar ratio of unlabeled peptide and Amy1 mediator peptide at 25 µM, in 50 
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mM PBS, 150 mM NaCl, pH 7.4. Initially, only a single diffusion coefficient is observed. 
Measurements on subsequent days indicated that larger species were present in solution. 
The large difference in the diffusion coefficient from the first day of sample measurement 
suggests that the Amy1 peptide is most likely inducing the aggregation state of the 
peptide as results for the control peptide indicated that only small species were present in 
solution up to about the fifth day of measurement. The large differences (randomness) in 
the percent signal amplitudes simply reflect the heterogenous nature of the sample. As 
different regions of the sample are selected for photobleaching during FPR measurement, 
this implies that the aggregates are not uniformly distributed within the sample cell.   


























Figure 5.23 Diffusion coefficients as a function of time for 5-carboxy-fluorescein Aβ (5-
CF-Aβ) mixed with unlabeled Aβ. Conditions: 10 µM 5-carboxy-fluorescein Aβ mixed 
with 25 µM unlabeled Aβ prepared in 50 mM PBS, 150 mM NaCl, pH 7.4. 
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Figure 5.25 shows the diffusion behavior of 10 µM 5-carboxy-fluorescein Aβ and a one- 
to-one molar ratio of unlabeled peptide and Amy2 mediator peptide at 25 µM, in 50 mM 
PBS, 150 mM NaCl, pH 7.4. In contrast to Amy1 and the control samples, large 
aggregates were observed immediately after sample preparation. This is reflected in the 
range of diffusion values shown in Figure 5.25. There was no time dependence on the 
aggregation behavior of the Amy2 peptide with Aβ as the lowest diffusion values seem to 
be stabilized around (3.51 ± 1.8) × 10-10 cm2s-1.  




























Figure 5.24 Diffusion coefficients as a function of time for 5-carboxy-fluorescein Aβ (5-
CF-Aβ) mixed with unlabeled Aβ and Amy1. Conditions: 10 µM 5-carboxy-fluorescein 
Aβ mixed with 1:1 molar ratio of unlabeled Aβ and Amy1 at 25 µM, prepared in 50 mM 
PBS, 150 mM NaCl, pH 7.4. 
 
 Figure 5.26 shows the diffusion behavior of 10 µM 5-carboxy-fluorescein Aβ and 
a one-to-one molar ratio of unlabeled peptide and Modified Amy mediator peptide at 25 
µM, in 50 mM PBS, 150 mM NaCl, pH 7.4. The trend in the diffusion coefficient results 
appears identical to that of the control peptide in Figure 5.23. The only difference is in 
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the percent signal amplitude on day 7, where the Modified Amy peptide has a higher 
percentage of large diffusers than the control Aβ peptide. This suggests that the Modified 
Amy mediator peptide has a cat and mouse approach to mediating Aβ peptide 
aggregation. 
















 single exponential 
double exponential
















Figure 5.25 Diffusion coefficients as a function of time for 5-carboxy-fluorescein Aβ (5-
CF-Aβ) mixed with unlabeled Aβ and Amy2. Conditions: 10 µM 5-carboxy-fluorescein 
Aβ mixed with 1:1 molar ratio of unlabeled Aβ and Amy2 at 25 µM, prepared in 50 mM 
PBS, 150 mM NaCl, pH 7.4. 
 
 
Both peptides co-exist in solution with the Modified Amy being the watch(cat) of the Aβ 
peptide activity. It appears that as soon as any Aβ aggregation begins, the Modified Amy 
works to destroy those aggregates most likely by binding to Aβ. The Murphy and 
Meredith peptides, Figure 5.27 and 5.28 respectively, both seem to utilize similar 
mechanisms for mediating Aβ peptide assembly. 
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Figure 5.26 Diffusion coefficients as a function of time for 5-carboxy-fluorescein Aβ (5-
CF-Aβ) mixed with unlabeled Aβ and Modified Amy. Conditions: 10 µM 5-carboxy-
fluorescein Aβ mixed with 1:1 molar ratio of unlabeled Aβ and Modified Amy at 25 µM, 
prepared in 50 mM PBS, 150 mM NaCl, pH 7.4. 
 
 
 Figure 5.29 top, shows the diffusion behavior of 10 µM 5-carboxy-fluorescein Aβ 
and a one to one molar ratio of unlabeled peptide and the one-directional [9]-6 arborol 
molecule at 25 µM, in 50 mM PBS, 150 mM NaCl, pH 7.4. The trend in the diffusion 
results seems to mimic that of Amy2 with the exception that no large diffusers were 
observed on day 1. The one-directional [9]-6 arborol has been found to be very surface 
active molecules.155 Transmission electron microscopy (TEM) of Aβ in the presence of 
one-directional [9]-6 arborol revealed the presence of large micellar-type structures 
similar to results obtained for one-directional [9]-6 arborol alone at concentrations 
exceeding its critical micelle concentration (CMC). It appears that the one-directional [9]-
6 arborol is behaving like a cosurfactant to stabilize the Aβ aggregation. 
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Figure 5.27 Diffusion coefficients as a function of time for 5-carboxy-fluorescein Aβ (5-
CF-Aβ) mixed with unlabeled Aβ and Murphy. Conditions: 10 µM 5-carboxy-fluorescein 
Aβ mixed with 1:1 molar ratio of unlabeled Aβ and Murphy at 25 µM, prepared in 50 







Figure 5.28 Diffusion coefficients as a function of time for 5-carboxy-fluorescein Aβ (5- 
CF-Aβ) mixed with unlabeled Aβ and Meredith. Conditions: 10 µM 5-carboxy-
fluorescein Aβ mixed with 1:1 molar ratio of unlabeled Aβ and Meredith at 25 µM, 
prepared in 50 mM PBS, 150 mM NaCl, pH 7.4. 
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To get a better idea of the nature of the species that formed in solution, an aliquot 
of the sample was examined by TEM. Figure 5.29, middle and bottom, shows TEM 
images of the 10 µM 5-carboxy-fluorescein Aβ and a one to one molar ratio of unlabeled 
peptide and the one-directional [9]-6 arborol molecule at 25 µM, in 50 mM PBS, 150 
mM NaCl, pH 7.4 negatively stained with 2% uranyl acetate. The top image was taken at 
a magnification of 50KX and the bottom image was taken at a magnification of 100 KX. 
The small, spherical-type lighter areas in the images are characteristic of the aggregation 
behavior of the arborol molecule.152 Although the top image appeared to have some 
‘barely’ visible fibrillar-mesh in the background, closer examination of the sample at 
higher magnification did not reveal the obvious presence of fibrils. 




























Figure 5.29 Top: Diffusion coefficients as a function of time for 5-carboxy-fluorescein 
Aβ (5-CF-Aβ) mixed with unlabeled Aβ and one-directional 9-6 arborol. Conditions: 10 
µM 5-carboxy-fluorescein Aβ mixed with 1:1 molar ratio of unlabeled Aβ and Amy1 at 
25 µM, prepared in 50 mM PBS, 150 mM NaCl pH 7.4.                       (figure continued) 
 




Figure 5.29 (continued) Middle and Bottom: TEM images of the 5-carboxy-fluorescein 
Aβ (5-CF-Aβ) mixed with unlabeled Aβ and one-directional 9-6 arborol negatively 
stained with 2% Uranyl acetate. Middle image was taken at a magnification of 50KX and 
the Bottom image was taken at a magnification of 100 KX. 
 
 
 A dynamic light scattering experiment was used to follow the behavior of the 
mediator peptides in the presence of Aβ. Figure 5.30 shows a simple DLS experiment 
designed to assess the the behavior of the Murphy peptide against large Aβ fibrils. After 
disrupting the large and slowly growing fibrils by sonication, the system remains stable 
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for hours. This suggests that aged, broken fibrils are not easily healed. Addition of the 
Murphy peptide rapidly accelerates fibril growth. This experiment is effective for 
screening mediator peptides and can help guide the synthesis of new materials. 
 







in 100% DMSO followed by dilution
in PBS pH 7.4
Sonicate in water bath for 10 mins 
with probe sonicator 
Addition of 5µL of 500µM 









Figure 5.30 Growth kinetics of β-amyloid at physiological pH. β-amyloid was dissolved 
in neat DMSO at a concentration of 1 mg/mL followed by dilution in 50 mM PBS, 150 
mM NaCl, pH 7.4, yielding a concentration of 100 µM. The apparent hydrodynamic 
radius was determined from cumulant analysis of dynamic light scattering data taken at 
90° scattering angle. 
 
 Figure 5.31 shows the dynamic light scattering results for Aβ in the presence of 
Amy1 and Amy2 mediator peptides at two different ratios (1:1 and 1:5). The 
hydrodynamic radius of the Aβ is greatly accelerated in the presence of Amy2. In 
contrast, in the presence of the Amy1 peptide, the Aβ is only slightly larger than the 
control.  
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Figure 5.31 Dynamic light scattering results of Aβ and its interaction with peptide-based 





Fluorescence photobleaching recovery (FPR) studies on 5-carboxyfluorescein 
labeled β-amyloid peptide solutions readily confirmed the coexistence of large and small 
species. This routine experiment can effectively screen inhibitors and can guide the 
synthetic enterprise.  To address the question of reversibility, and to improve the 
economy of experimenting with expensive Aβ peptide and inhibitors, in situ dialysis cells 
for DLS and FPR were developed.  The reversibility of the peptide conformation from 
the low oligomeric state to the aggregated state under neutral and acidic pH conditions 
and confirmed that the peptide growth increased with increasing ionic strength. 
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CHAPTER 6 
INTERACTION BETWEEN β-AMYLOID PEPTIDE AND LIPID BILAYERS 
 
6.1 Introduction 
   The earliest experimental studies to predict that lipid molecules in membranes 
were organized bilayers were done by E. Gorter and F. Grendel in 1925.156  Later, studies 
performed with instrumental techniques such as X-ray diffraction, freeze-fracture 
electron microscopy and X-ray crystallography helped confirm that the lipid bilayer 
provides the basic structure of biological membranes.  These experiments provided vital 
evidence to support the fluid mosaic model of membrane structure proposed by S. J. 
Singer and G. L. Nicolson in 1972.157 Although the Singer model appears simple in view 
of the considerable progress that has been made in unraveling the complexity of 
biological membranes, it remains a useful starting point for comprehending cellular 
membrane structure.  
  The major constituent of all biological membranes is lipid molecules (30 – 80%), 
proteins (20 – 60%) and carbohydrates (0 – 10%). The lipid bilayer has a typical 
membrane thickness of 4-5 nm and has been described as a fluid matrix, within which 
protein molecules are attached, adsorbed, inserted or embedded. Among the major types 
of lipids present in the cell membrane, the phospholipids are the most common, followed 
by cholesterol and glycolipids. The structure, composition and interaction of a lipid 
bilayer with membrane proteins determine its function. An important property of a lipid 
layer which is crucial to many of its function is its fluidity. The degree of fluidity may 
vary from being highly fluid to a partially fluid state depending on the arrangement and 
composition of membrane components. For example, cholesterol molecules are important 
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in maintaining the flexibility and stability of the cell membrane, but affect the lipid 
bilayer by decreasing its fluidity. Cell membranes must be in a relatively fluid state to 
maintain their normal biological function. Thus, it is necessary to understand the structure 
and dynamic properties of lipid molecules within the membrane environment, combined 
with their interaction with proteins as this may provide insight into the orientation and 
structural transformation that occurs upon insertion of proteins into lipid membranes.158  
  The discovery of liposomes (small artificial lipid vesicles) by A. Bangham in 
1962159 provided a suitable model system that closely mimicked natural cell membranes 
to study such fundamental processes.160;161 Several unique properties make vesicles ideal 
artificial membrane mimics.162;163 One advantage of lipid vesicles is their ability to form 
spontaneously in aqueous environments and self-assemble into structures such as 
monolayers or bilayers on solid supports (glass, quartz, mica, silicon chips).158;164-168 
Additional properties such as permeability to ions, and versatility (it is possible to vary 
and control composition, pH, and ionic strength) have made it possible to study a variety 
of physical parameters of these systems. For instance, tremendous effort is being applied 
to the study of the interactions and binding properties of various proteins and other 
molecules to lipid membrane surfaces. Extensive documentation exists on the potential 
uses of liposomes in a range of biological applications.169-171  
   Although scientists continue to gain deeper understanding of lipid vesicles and 
have, in some cases, been able to correlate these fundamental properties with those of 
natural membranes, major areas of research remain to be explored.172 Tremendous effort 
is being directed towards development of biophysical techniques, and progress is being 
made in the areas of pathogen attack,173 inflammatory response, design of more realistic 
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and sophisticated model membrane systems (tethered polymer-supported lipid bilayer 
artificial membranes),174-176 and membrane pathologies that result in cellular 
dysfunction.177 
  The objective of this work is to develop model membrane systems to study the 
interaction between β-amyloid peptide (Aβ) and lipid bilayers and understand how the 
lipid membrane affects the properties of Aβ (and vice versa). Specifically, the effect the 
Aβ peptide attribute to the fluidity of the lipid membrane will be addressed. The results 
from several studies are misleading as some indicate that Aβ alters the membrane by 
increasing its fluidity while others report the opposite effect. The reader is directed to a 
review article by Wood et al.,178 for a summary of the studies dealing with the effects of 
Aβ on membrane fluidity both in model and biological membranes. The experimental 
results are clearly controversial and further investigations with suitable model systems 
and biophysical techniques are needed.  
6.2 Interaction of β-amyloid with Lipid Bilayers 
  Many researchers have investigated the interaction of Aβ with natural179-182 and 
artificial (brief review follows) lipid membranes. Based on its amphiphilic nature, Aβ can 
interact with membranes resulting in several membrane perturbing effects, which may 
play a pivotal role in the pathogenic casade leading to Alzheimer’s disease. It remains a 
difficult task to pinpoint the exact mechanism via which Aβ becomes toxic to cells. 
Nevertheless, it is evident that the concentration of Aβ found in cerebrovasular fluids in 
vivo is insufficient to initiate fibril growth in vitro. Thus, it is possible that the toxicity of 
Aβ to cells may result from a direct consequence of specific interactions upon binding to 
the membrane surface. In fact, several researchers have found evidence that the Aβ 
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changes conformation from a random coil to β-sheet upon binding the membrane. The β-
sheet structure adopted by the Aβ peptide is crucial for formation of fibrils; thus, if 
indeed interaction with the membrane surface initiates fibril formation, then this may 
account for the low concentrations of the peptide found in vivo. 
   Terzi et al.183 demonstrated that the binding of monomeric Aβ25-35 peptide to 
negative lipid vesicles is possible primarily through electrostatic interactions. Subsequent 
studies with the Aβ1-40 peptide by Terzi et al.184;185 and later, Bokvist et al.186 revealed 
that a conformational change from random coil to β-sheet structure occurs when the 
peptide binds negatively charged, small unilamellar lipid vesicles (SUV) (under 
conditions of low ionic strength; about 5 -10 mM MOPS or Tris buffer, without NaCl); 
neutral membranes had no effect on the monomeric form of the peptide. Terzi et al.185 
failed to observe a conformational change at physiological ionic strength. Studies by 
McLaurin et al.187 also confirmed that negatively charged membranes can induce a 
conformational change from random coil to β-sheet in the Aβ1-40 peptide in the presence 
of SUVs but only under conditions of lowered pH values. 
  In alternate studies, Choo-Smith et al.188 varied the membrane system to include 
ganglioside as it was believed that the ‘lipid rafts’ are the preferential site for the 
formation of the Aβ fibrils. Several other studies have confirmed the accelerated 
formation of Aβ fibrils in the presence of membranes composed of sphingomyelin and 
cholesterol.189-192 Other effects that have been reported to result from the interaction of 
the Aβ peptide with membranes include: formation of Ca2+ channels and ion pores193-195. 
Despite the limitations of these studies, it is plausible that interaction of the Aβ peptide 
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induces changes (subtle or otherwise) in the membrane environment which may be 
deleterious to the cells.  
6.3 Measuring Diffusion with FPR   
   To study the effect of Aβ on lipid membranes a combination of fluorescence 
photobleaching recovery (FPR) and fluorescence microscopy was used. The detailed 
technical information of FPR is presented in Chapter 4.  Hence, a brief summary of the 
suitability of this technique will be given. Many of the physiological functions of the cell 
membrane depend on its mobility: transport of nutrients and waste into and out of the 
cell, membrane fusion and cell interaction, responding to signals in the cellular 
environment. The classic experiment by L. Frye and M. Edidin in the 1970s demonstrated 
that membrane proteins diffuse freely in the lipid bilayer, implying that they were 
fluid.196 Frye et al.196 labeled antigens at the surface of mouse and human cells with green 
and red fluorescent dyes respectively. The cells were fused with Sendai virus to form 
heterokaryons with both mouse and human surface antigens localized within specific 
regions of the ‘newly-formed’ cells. The cells were incubated and later observed with a 
microscope. While initially the red and green dyes were separated, through diffusion, the 
molecules were found randomly distributed over the entire cell surface.  
   One great advantage of FPR is the fact that it was developed (and has been 
successfully used) for studying the diffusion of molecules in biological systems, 
including proteins and lipid within membranes.61;93;95-97;197-199 Fundamentally, the FPR 
technique was designed with a similar concept to the experiment of Frye et al. Briefly, a 
small spot in a fluorescently labeled sample is photobleached and the region is monitored 
to detect the return of fluorescence as bleached and unbleached molecules randomize 
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their positions through translational diffusion.200 Thus, FPR has been established as an 
ideal technique for measuring mobility of molecules within membranes and should prove 
effective for obtaining information on the nature of membrane fluidity upon interaction 
with the Aβ peptide.   
6.4 Interaction of Melittin with Lipid Bilayers 
 
 Melittin, the major toxic component of the venom of the honey bee, Apis 
mellifera, is among the best-studied amphipathic α-helical polypeptides.201;202 Its 26- 
amino-acid-sequence is arranged such that the amino-terminal part (residues 1-20) is 
predominantly hydrophobic, whereas the carboxy terminal region (residues 21-26) is 
hydrophilic and strongly basic, due to four positively charged (Lys-Arg-Lys-Arg) amino 
acid residues.203;204 As a consequence of its structure, melittin binds natural, as well as  
negatively charged and zwitterionic, phospholipid artificial membranes resulting in 
different but profound effects in each case.205 Studies have reported that melittin forms 
transmembrane pores via a “barrel-stave” mechanism in zwitterionic lipid bilayers, while 
it acts like a detergent, (solubilizing membranes) via a “carpet-like” mechanism in 
negatively charged membranes.206-209  Melittin has also been found to induce the fusion 
of both small and large zwitterionic and acidic vesicles resulting in large structures.210-213 
Although characterization of the various effects of melittin on membranes is not 
complete, it has been a convenient model in providing insight into complex membrane 
protein interactions.      
Several of the characteristics of melittin were found to be similar to the properties 
of the Aβ peptide; thus, melittin was chosen as a useful reference for comparison of the 
lipid-peptide interactions in lipid bilayers. A few striking parallels between the two 
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peptides are: their ability to change conformation upon binding to membrane, resulting in 
changes in the membrane morphology; their ability to exert their toxic effects upon 
interaction with membranes; and, their ability to form defects in membrane structure, 
such as pores and channels. In this study, the interaction of melittin with vesicles and 
lipid bilayers on mica was examined with fluorescence photobleaching recovery and 































Phosphocholine (18:1-12:0 NBD PC) 
 
 Figure 6.1. Chemical structures of the phospholipids POPC and the fluorescent probe 
NBD-PC used in this study. 
 
   For this study all lipids used, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
(POPC) in chloroform, and 1-oleoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-
yl)amino]dodecanoyl]-sn-glycero-3-phosphocholine (NBD-PC) in chloroform, were 
purchased from Avanti Polar Lipids, Inc. Chloroform (99.9% HPLC grade) was 
purchased from Aldrich Chemicals. Melittin was purchased from Sigma. β-amyloid 
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peptide was purchased from Anaspec, Inc. Imaging chamber (20 mm diameter, 1 mm 
deep was purchased from Sigma-Aldrich. All fluorescent-probe-containing solutions 
were wrapped in aluminum foil and stored in the dark to prevent photobleaching from 
room light. Nanopure water for all experiments was obtained by a Barnstead Nanopure 
Water System (18 MΩ cm) resistivity. 
 
6.6 Preparation of Lipid Vesicles 
 
  The preparation of lipid vesicles of the right size and structure involves three basic 
steps: first, prepare the lipid for hydration by first drying off organic solvents from the 
lipid, resulting in a film; second, hydrate the lipid film in aqueous media; third, downsize 
the formed hydrated lipid vesicles by sonication or extrusion.214 In this study, the lipids 
POPC (1.9 mg) and NBD-PC (0.1 mg) were both dissolved in chloroform at the 
concentration of 2 mg lipid/ mL of chloroform in a Pyrex test tube (13 × 100 mm) to 
ensure a homogeneous mixture of lipids. Additional chloroform (1-2 mL) was added and 
thoroughly mixed to ensure optimal film formation. The chloroform was subsequently 
removed by rotatory evaporation (Buchler Instruments) for about 20 minutes, yielding a 
thin lipid film in a round bottom flask. Residual chloroform was removed by placing the 
flask in a vacuum oven overnight. The dried lipid film was hydrated with a 2-mL aliquot 
of a 50 mM phosphate-buffered saline buffer, 150 mM NaCl at pH 7.4 and placed on a 
rotatory evaporator without a vacuum – spinning the round bottom flask in a water bath 
to maintain a temperature above the Tm of the lipid suspension for about one hour. 
   The resulting hydrated large, multilamellar vesicles (MLVs) were disrupted by 
either sonication or extrusion to form small, unilamellar vesicles. Initally, the lipid 
solution was sonicated with a micro tip Branson Sonifier 450 on an on-off cycle for five 
 102  
minutes total. The sonication tip was found to release titanium particles into the lipid 
suspension, which need to be removed by centrifugation. In other cases, the sample was 
often heterogeneous between batches. It was difficult to control and reproduce the 
conditions of sonication, thus an alternate method was used. 
   The disruption of the MLV suspension was achieved by using the lipid extrusion 
technique. Prior to disruption, the MLVs were alternately frozen in liquid nitrogen and 
thawed in hot water (60 °C) for five freeze-thaw cycles to improve homogeneity of the 
final lipid suspension. The MLVs were then extruded for 20 complete cyles through an 
Avestin polycarbonate filter (100 nm pore size) on a liposofast-basic manual extrusion 
apparatus. The diameter of the vesicles was measured by dynamic light scattering and a 
value of 100-120 nm was found (near the pore size of the filter used). All vesicles in this 
study were prepared by the extrusion technique because this method proved more 
reproducible than sonified lipid vesicles.  
6.7 Formation of Lipid Bilayers  
  Lipid bilayers have a natural tendency to form spontaneously215 (i.e. ∆G < 0), by 
fusion or adsorption into a continuous bilayer membrane on several materials.216 The 
formation of a lipid bilayer by vesicle adsorption on a hydrophilic surface involves three 
steps: adsorption, rupture and spreading.217 The adsorption of lipids onto hydrophilic 
surfaces is spontaneous due to the presence of the hydrophilic phosphate headgroups at 
the outer surface of the vesicles. The electrostatic environment with fixed charges due to 
the phosphate and choline groups218 causes the vesicles to flatten out onto the surface, 
after which the vesicles are ruptured. Spontaneous spreading is facilitated by the presence 
of a thin (1-2 nm) film of water216;219-222 (‘precusor film’) located between the vesicles 
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and the hydrophilic surface. Strong self-assembly forces causes phospholipid membranes 
of almost constant thickness to form as the membrane is very thin and close to the 
hydrophilic surface.223 A schematic representation for vesicle interactions with 











Figure 6.2. Schematic representation of vesicle fusion on a hydrophilic surface. Adapted 
from reference 221.  
 
   The supported lipid bilayers were formed by pipetting a drop of the vesicle 
solution (lipid concentration of 2 mg/mL) onto a freshly cleaved mica disk (10 mm) 
which had been glued onto a mica puck and placed on a microscope slide. The sample 
was allowed to incubate at room temperature for one hour in a covered Petri dish that had 
been layered with a moist filter paper.  After the incubation period, the sample was rinsed 
with phosphate buffer to remove any unfused vesicles and a small volume of the buffer 
was kept on the membrane at all times to prevent interference with the liquid-air 
interface. The sample was then sealed with an imaging chamber to prevent air flow that 
 104  
could cause the liquid interface to move and also to prevent evaporation of the buffer 
which would result in drying of the sample.224 For FPR studies involving the lipid 
vesicles in solution, the samples were loaded in 0.2-mm-path-length rectangular 
microslides (Vitrocom) by capillary action, and the microslides were flame-sealed. 
6.8 Results 
6.8.1 Fluorescence Imaging and FPR Analysis of Supported Lipid Bilayers 
 
 To obtain information on the structural and dynamic properties of supported 
phospholipid bilayer on mica, fluorescence microscopy and fluorescence photobleaching 
recovery (FPR) techniques were used. Representative fluorescence microscopy images 
for mixed POPC/NBD-PC bilayers formed by direct vesicle fusion on mica observed at 
different time points during experimentation are shown in Figure 6.3. It should be noted 
that images such as those appearing in Figure 6.3 a-c were rarely observed, but the 
patterns evidenced therein are recognized as important steps in the formation of defect-
free supported membranes. The appearance of mobile unruptured spherical vesicles can 
be seen in Figure 6.3a. This may be attributed to residual unfused vesicles that were not 
completely rinsed away during sample preparation. Some defects can be observed in 
Figure 6.3b due to incompletely formed membrane. Due to the mobility of the lipid 
membrane, complete coverage of the surface is possible with additional time. The image 
in Figure 6.3c was taken near the edge of the mica supported bilayer. A portion of the 
lipid bilayer has holes and is separated by a portion that is defect free. It is not known 
what caused the holes, but one can speculate that some tension, perhaps at the air-water 
interface may have contributed to its formation. These holes can be likened to similar 
‘circular defects’ observed in cholesterol containing planar ‘raft’ model membranes.219  
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Figure 6.3. Fluorescence microscopy images of supported phospholipid bilayers on mica. 
(a) spherical unfused vesicles floating on the membrane, (b) incompletely formed 
membrane with defects, (c) holes within the lipid bilayer (d) uniform supported lipid 
bilayer on mica. (Images were false colored with Adobe Photoshop). 
 
Crane et al.219 reasoned that the circular defects in their fluorescence microscopy images 
were possibly due to surface defects in the solid support or stretching during deposition 
of the first lipid layer by the direction of the Langmuir-Blodgett. The uniformly (within 
optical resolution) continuous supported membrane shown in Figure 6.3d was typically 
used for experimentation. 
a) b) 
c) d) 
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There are several methods to test the integrity of supported membranes formed by 
vesicle fusion. While fluorescence microscopy can be used to obtain structural 
information, it would not be an appropriate choice to determine the fluidity of a defect-
free bilayer that is uniformly fluorescent. If the membrane is scratched, however, then it 
should be possible to observe the fluidity of the membrane by its ability to spread into the 
scratched region. In Figure 6.4a, the mica was mechanically scratched with a razor blade 
prior to deposition of the vesicles onto its surface. The observed scratch was not ‘healed’ 
following incubation for one day, suggesting that spreading was unfavorable.164 Groves 
et al.216 demonstrated that under neutral or basic conditions, scratch barriers are very 
stable, whereas they heal in minutes under mildly acidic conditions. The scratch-free 
regions within the bilayer were found to be ‘fluid’ by measurement of diffusion 
coefficient with FPR. The stability of the scratch in the bilayer can be viewed as an 
example of a barrier to lateral diffusion, in keeping with the natural ability of cell 
membranes to restrict access to unwanted components. A stripe pattern photobleached 
into a lipid bilayer is shown in Figure 6.4b. 
FPR is an established technique for measuring lateral mobility and hence 
determining the fluidity of lipid membranes.175 Supported membranes have been 
demonstrated to exhibit many features of natural membranes including lateral fluidity. To 
determine whether the prepared lipid membrane maintained its dynamic properties on the 
mica support, its lateral diffusion was measured by FPR. The diffusion coefficient of both 
NBD-PC/POPC vesicles and lipid bilayer on mica support was assessed by this method. 
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Figure 6.4. Fluorescence microscopy images of supported phospholipid bilayers on mica. 
(a) lipid bilayer which has been scratched (b) image of stripe pattern bleached into the 
supported lipid bilayer, acquired with a 10× objective. The black spot is due to 
photobleaching during a previous exposure at 63×, final objective 10× magnification. 
(Image 6.4a was false colored with Adobe Photoshop). 
 
 
The diffusion coefficient of the NBD-PC/POPC vesicles was determined to be (4.93 ± 
0.27) × 10-8 cm2s-1 (Figure 6.5a). A typical FPR recovery profile appears in Figure 6.5a. 
The inset shows a plot of Γ vs K2 whose slope provides the diffusion coefficient. The zero 
intercept, within experimental error, indicates true Brownian diffusion rather than 
relaxation due to convection or reversible photobleaching.225  A semilogarithmic FPR 
trace of the data points in Figure 6.5a displays almost single exponential behavior, 
indicating that the lipid vesicles were uniformly composed (Figure 6.5b).  
After fusion of the NBD-PC/POPC vesicles with the mica surface to form a lipid 
bilayer as in Figure 6.3d, the NBD-PC was observed to have a diffusion coefficient of 
(5.99 ± 0.55) × 10-8 cm2s-1 (Figure 6.6a). The semilogarithmic plot also displays almost 
single exponential behavior similar to the lipid vesicles (Figure 6.6b). 
 
a) b) 
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Figure 6.5. Diffusion measurement of phospholipid vesicles in suspension. (a) Recovery 
profile for NPD-PC/POPC (5:95 molar ratio) phospholipid vesicles. Inset: Γ vs K2 plot of 





 109  

























































Figure 6.6. Diffusion measurement of NBD-PC in a phospholipid bilayer. (a) Recovery 
profile for NPD-PC/POPC (5:95 molar ratio) phospholipid bilayer on mica support. Inset: 
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 The diffusion coefficient values obtained for NBD-PC probe lipid in both mica 
supported bilayers and vesicles composed of NBD-PC/POPC (5/95 mol/mol) suggests 
that membranes diffuse. The measured diffusion coefficients were also in the range (1-8 
× 10-8 cm2s-1)94;165;226 reported for diffusion of phospholipid molecules in fluid 
bilayers.222;227;228 After obtaining the diffusion coefficient of the lipid vesicles and 
bilayers, it was determined that the membrane was sufficiently fluid and within the 
expected values in literature. Thus, similar experiments were performed to determine the 
interaction of the β-amyloid peptide and, later, melittin with lipid vesicles and lipid 
bilayers.  
6.8.2 Fluorescence Imaging and FPR analysis of the Interaction of β-amyloid with      
Lipid Bilayers 
 
 Most studies have used fluorescence anisotropy to determine how Aβ affects the 
fluidity of lipid membrane. As discussed earlier, discrepancies exist as to whether the Aβ 
peptide increases or decreases the fluidity of the membrane. To address how Aβ alters 
membrane fluidity, FPR was used to determine the diffusion of a fluorescent lipid probe, 
1-Oleoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-sn-Glycero-3-
Phosphocholine (NBD-PC) on a mica-supported model membrane system made of 5% 
NBD-PC and 95% 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) as the 
major component. Figure 6.7 shows the trend of the surface diffusion of NBD-PC in a 
bilayer with POPC as a function of time. The bilayer was incubated with pre-formed Aβ 
protofibrils, followed by rinsing with buffer to remove any unbound material - the buffer 
was used to keep the bilayer moist throughout the experiment. The data implies that the 
fluidity of the lipid is compromised by the presence of fibrils, as indicated by the 
decreasing diffusion results with time. 
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Figure 6.7. Diffusion of 5% NBD-Labeled PC fluorescent tracer molecule in 95% 
unlabeled POPC on mica with preformed β-amyloid1-40 fibrils.   
 
 
To further explore the interaction of Aβ with lipid bilayer model membranes,  
lipid bilayers were prepared as described previously and an aliquot of a 50 µM unlabeled 
Aβ sample prepared in 50 mM PBS, 150 mM NaCl, pH 7.4 was applied to the wet lipid 
bilayer. Fluorescence microscopy images taken at different areas in the sample revealed 
that the presence of the bilayer induced the aggregation of the peptide (Figure 6.8). To 
further explain the appearance, it is hypothesized that the Aβ picks up some NBD-PC as 
it forms aggregates. To determine whether the prepared lipid bilayers maintained its 
dynamic properties on the mica support, its lateral diffusion was measured by FPR. 
Figure 6.9 shows the trend in the diffusion coefficient of NBD-PC in a bilayer with 
POPC as a function of time. Two diffusion modes which differed by orders of magnitude 
were calculated. The slow mode was dominant with about 80% of the signal amplitude. 
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There was almost no change in the diffusion coefficient for the duration of the 
experiment.  
      
     
Figure 6.8. Fluorescence microscopy images showing the interaction of unlabeled β-
amyloid peptide with supported phospholipid bilayers on mica. (a-d) changes in the lipid 
membrane at different regions in the sample. 
 
The interaction of Aβ was further investigated with lipid vesicles in suspension. 
Figure 6.10 shows the diffusion values as a function of time. In contrast to the results 
obtained for the interaction of Aβ with lipid bilayers only one diffusion mode was 
obtained. The diffusion coefficient was only slightly lower than that of the vesicles alone.  
b) a) 
c) d) 
50 µm 50 µm 
50 µm 50 µm 
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Figure 6.9. FPR diffusion coefficient values of NBD-PC in the presence of β-amyloid on 
mica-supported lipid bilayer as a function of time. The percent of fast and slow signal 
amplitude are displayed. 
















 NBDPC POPC (Extrusion)
 NBDPC POPC + Abeta oligomeric peptide (1:10)
 
 
Figure 6.10. Diffusion of NBD-PC in vesicles composed of NBD-PC/POPC (5/95 mol 
percent) in the presence of preformed β-amyloid1-40 fibrils (1:10 molar ratio).   
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Like the results obtained for the interaction of Aβ with lipid bilayers, there was almost 
almost no change in the diffusion value as a function of time. These later results are 
consistent with findings in the literature that the Aβ does not alter the properties of 
zwitterionic lipid vesicles. 
6.8.3 Fluorescence Imaging and FPR Analysis of Interaction of Melittin with Lipid 
Bilayers 
 
 Melittin was chosen as a control molecule due to its profound ability to affect the 
properties of natural, as well as negatively charged and zwitterionic, phospholipid 
artificial membranes. FPR was used to determine whether melittin induced any changes 
in the dynamic properties of the lipid bilayer on a mica support. Figure 6.11 shows the 
trend in the diffusion value as a function of time. 
























Figure 6.11. FPR diffusion coefficient of NBD-PC in the presence of melittin on mica-
supported lipid bilayer as a function of time. The percent of fast and slow signal 
amplitude are displayed. 
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The results are almost identical to those obtained for the interaction of Aβ with lipid 
bilayers, with the expection being that the percent signal amplitude was lower by almost 
20% for the slow diffusers. Additional experiments were performed to investigate the 
interaction of melittin with lipid vesicles.  
      
Figure 6.12. Fluorescence microscopy image showing the interaction of melittin with 
vesicles composed of 5% NBD-Labeled PC/95% unlabeled POPC (1:1 molar ratio). (a) 
after 3hrs, (b) after 7.5 hrs.   
 
Figure 6.12 shows fluorescence microscopy images of a one to one molar ratio of melittin 
with lipid vesicles at 3 and 7.5 hours after sample preparation. The initial presence of 
small spherical vesicles shown in white against a green background is observed in Figure 
6.12a. The growth of the vesicles became more apparent after 7.5 hours. The trend in the 
diffusion values as a function of time is shown in Figure 6.13. The fact that the sample 
was a polydisperse population of several species is clearly demonstrated by the multiple 
exponential analysis results and better yet by the 3-D representation of the CONTIN 
distribution of the data in Figure 6.13 bottom.  
 
a) b) 
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Figure 6.13. Top: Diffusion of NBD-PC in vesicles composed of NBD-PC/POPC (5/95 
mol percent) in the presence of melittin. Bottom: 3-D representation of CONTIN 
distribution of data. 
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Figure 6.14. Contrast of melittin at zero and 7.5 hours in lipid vesicles. 
  
 
The deviation from single exponentiality of the signal contrast at time 3 and 7.5 hours in 
Figure 6.14 also suggests accurate analysis of the sample composition. Unlike the Aβ 
peptide, the results clearly show that melittin interacts with zwitterionic lipid vesicles and 




          FPR was used to investigate the effect of Aβ on membrane fluidity. For 
comparison, melittin was chosen as a control molecule as it has been found to induce 
changes in the dynamic properties of lipid bilayers. The results from initial FPR 
experiments for the diffusion of tracer lipid molecules composed of the fluorescent lipid 
probe, 1-Oleoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-sn-
Glycero-3-Phosphocholine (NBD-PC) and  1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC) at a ratio of 5% NBD-PC to 95% POPC (supported on mica) 
was consistent with diffusion coefficient values reported for phospholipids molecules in 
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fluid bilayers. Upon incubating the Aβ on the bilayers, there was a marked decreased in 
the diffusion coefficient values, indicating that the presence of the fibrils hindered the 
diffusion of the lipid probe, suggesting that the Aβ acts to decrease the fluidity of the 
lipid membrane. Fluorescence microscopy images revealed that the Aβ peptide perturbs 
the composition of the bilayers and increased aggregation of the peptide was observed. In 
studies examining the interaction of Aβ with zwitterionic lipid vesicles, there was no 
change in the diffusion values. The melittin control on the other hand, vastly induced the 
aggregation of the lipid vesicles. This suggests that bilayer surface may play a pivotal 
role in the Aβ aggregation mechanism. Perhaps, the lipid membrane is acting as a 
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APPENDIX A: FLUORESCENCE SPECTROSCOPY  
 
Table with sample identification using a 96-well plate layout. 
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A screen capture of fluorescence spectroscopy results plotted in an Excel spreadsheet 
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APPENDIX B: HIGH PRESSURE INSTRUMENTS 
 




Photograph of high pressure cell set-up (Location A, UNICAMP, Campinas, Sao Paulo, 
Brazil) 
 
Both vial and cap are filled with the sample and 
covered – care should be taken to avoid air bubbles. 
The vial is subsequently inserted into a sample holder 
within the ethanol filled high pressure cell chamber. 
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Photograph of high pressure cell set-up (Location A, UNICAMP, Campinas, Sao Paulo, 
Brazil) 
 
The high pressure cell is then placed  
within a modified Edinburg FL 900 
spectrofluorometer chamber and the pressure 
generator connected to the top of the cell.  
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Photograph (courtesy of Dr. Rafael Cueto) of high pressure cell set-up (Location B, 
Louisiana State University, LA) 
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Photograph (courtesy of Dr. Rafael Cueto) of high pressure cell set-up (Location B, 
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